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ABSTRACT 
This dissertation is based on the hypothesis that neural grafts may rescue/protect the 
host central nervous system (CNS) from induced and hereditary neurodegeneration. This 
hypothesis becomes especially intriguing in the context of neural stem cells (NSCs) that 
contribute to CNS plasticity and show therapeutic promise in neurodegenerative 
environments where oxidative stress plays a pathophysiological role. Unfortunately, little is 
known about the NSC's intrinsic sensitivity to oxidative stress and how it relates to their 
potential to protect and repair the CNS. The present study therefore investigates the cellular 
and molecular bases of neural stem cell (NSC)-mediated neuroprotection, in a model of 3 
nitropropionic acid (3-NP)-induced oxidative stress and neurodegeneration. Specifically, we 
studied in vitro and in vivo, the 1) alertness of antioxidant defenses and their contribution to 
the NSC's sensitivity and response to 3-NP, and 2) interactions of NSCs with their local 
cellular microenvironment, which helped maintain homeostasis and cell survival. 
The first part of our work analyzed in vitro cell survival and free radical levels in 
NSCs and their more differentiated counterparts (post-mitotic neural progenitors; PNPs) both 
at steady state and after exposure to 3-NP. We found that NSCs exhibited greater basal 
mitochondrial activity, lower intracellular reactive oxygen species (ROS) levels, and higher 
expression of key antioxidant enzymes, such as uncoupling protein 2 (UCP2) and glutathione 
peroxidase (GPx) than PNPs. On 3-NP exposure, PNPs showed rapidly increasing ROS 
levels and cell death. NSCs on the other hand were able control the ROS up rise and survive 
due to stronger antioxidant up-regulation. This heightened "vigilance" of antioxidant defense 
mechanisms might represent a basic NSC characteristic, which not only influences their fate, 
but also contributes to their ability to be therapeutically useful in the diseased CNS. 
ix 
As the next step, we examined interactions of NSCs with their microenvironment 
that lead to neuroprotection from oxidative stress. For this purpose, we applied 3-NP in vitro 
(co-cultures of NSCs and primary striatal cells) and in vivo (NSC-transplanted mice) and 
studied NSC interactions with their cellular vicinity which may lead to the activation of 
antioxidant defenses and finally cell survival. In both models, the presence of NSCs 
significantly improved cell viability by interfering with the production of free radicals and 
increasing the expression of neuroprotective factors. In vivo, animals grafted with NSCs 
before treatment with 3-NP exhibited reduced behavioral symptoms and neuronal cell loss 
than vehicle-injected controls. Importantly, during the neuroprotective process, NSCs were 
found to solicit the assistance of neighbouring primary or host glial and endothelial cells. 
The interaction between NSCs, astrocytes and endothelial cells reciprocally increased 
expression of ciliary neurotrophic factor (CNTF) and vascular endothelial growth factor 
(VEGF). Also, both in vitro and in vivo, the increase in both factors was accompanied by a 
robust up-regulation of the antioxidant enzyme superoxide dismutase 2 (SOD2) in neurons, 
promoting their survival. This study therefore provides information on how NSCs, via 
cellular networking in the "niche", may protect imperiled cells from the deleterious effects of 
oxidative stress. 
In summary, this dissertation identifies two important properties of NSCs not 
explored before, namely their innate alertness to oxidative stress, and their ability to interact 
with and induce plastic responses from within their microenvironment. These features allow 
NSCs to survive in a hostile CNS environment and empower them to protect the host from 
the arriving impact of oxidative stress. 
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CHAPTER I. GENERAL INTRODUCTION 
Dissertation Organization 
This dissertation investigates the cellular and molecular dynamics underlying NSC-
mediated neuroprotection. It contains the experimental results obtained by the author during 
her graduate study under the guidance and supervision of her major professors, Drs Jitka and 
Vaclav Ourednik. It is written in an alternative thesis format, and contains a general 
introduction, two research papers, a general conclusion and an acknowledgement. 
The general introduction (Chapter I) includes a research objective, and background 
and literature review of NSCs, oxidative stress, CNS regeneration, graft-induced host 
plasticity, neuroprotection and neuroprotective factors, and NSC-host interactions. 
The second chapter of the dissertation examines the alertness of antioxidant defenses, 
and their contribution to NSC sensitivity and response to oxidative stress. The third 
determines interactions of NSCs with their cellular microenvironment under oxidative stress 
and their role in neuroprotection. Both chapters are arranged in a paper format with the titles 
"Increased vigilance of antioxidant mechanisms in neural stem cells potentiates their 
capability to resist oxidative stress" and, "Neuroprotection from oxidative stress in the stem 
cell niche: cellular networks and regulation of antioxidant expression" by Madhavan L, 
Ourednik V, Ourednik J, and have been accepted by Stem Cells and accepted with revisions 
by The Journal of Neuroscience, respectively. 
Chapter IV consists of the general conclusions summarizing the current work on 
mechanisms underlying NSC-mediated neuroprotection. It then goes on to propose some 
possible directions for future research. 
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Research Objectives 
It has been shown that the interaction of transplanted NSCs with the CNS 
environment can stimulate protection/regeneration of host cells exposed to oxidative stress 
(Ourednik et al., 2002). Once the donor NSCs engraft into the recipient parenchyma, they 
integrate with their surroundings and get involved in a constant dialogue with host elements. 
During these events, and in the case of a pathological condition such as increased oxidative 
stress, NSCs are exposed to the hostility of the diseased CNS. In other words, the local host 
environment begins to affect NSC behavior and fate. In a similar manner, the transplanted 
NSCs also act to influence the local environment and change host cells in their vicinity. 
Thus, there is a bidirectional interaction between the grafted cell and its local three 
dimensional milieu which determines the outcome of NSC-transplantation. 
However, in this context of graft-host communication, not much is known about the 
NSC's own intrinsic sensitivity to oxidative stress and the NSC interactions with the 
surrounding host cells which lead to neuroprotection. This dissertation investigates NSC 
behaviors and interactions with its microenvironment under oxidative stress, in vitro and in 
vivo, and in relation to the neuroprotection. The major objectives of the conducted research 
were to: 
1. examine the intrinsic reactive oxygen species sensitivity and antioxidant 
capacity of NSCs and their effects on NSC behavior under oxidative stress, 
2. characterize the neuroprotective ability of NSCs under an environment of 
oxidative stress, and 
3. determine some of the cellular interactions with the local microenvironment 
underlying the neuroprotective potential of NSCs. 
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Background and Literature Review 
This section provides background information and literature review related to the 
studies presented in this dissertation. The information has been divided into the following 
subdivisions: 
(1) Overview of neural stem cells (NSCs) 
(2) Oxidative stress 
(3) CNS regeneration and NSCs 
(4) The concept of "graft-induced host plasticity" 
(5) Neuroprotection and neuroprotective factors 
(6) NSC interactions with its local environment 
Overview of neural stem cells (NSCs) 
Recent work in neuroscience has challenged the credo that new neurons are not 
generated in the adult mammalian CNS: In 1992, it was demonstrated that stem cells isolated 
from the forebrain can differentiate into neurons in vitro (Reynolds and Weiss, 1992). These 
results along with technical advances in the development of immunocytochemical reagents 
led to a burgeoning of subsequent stem cell research. Now, normally occurring neurogenesis 
in the subventricular zone (SVZ)/olfactory bulb and dentate gyrus of the hippocampus has 
been well characterized in the adult mammalian brain (Alvarez-Buylla and Lim, 2004). 
Stem cells in an organism can exist in various capacities (Gage, 2000). A totipotent 
stem cell can give rise to a full organism, including the nervous system. The pluripotent cell 
is the same as an embryonic stem cell (ES cell) and is somewhat more restricted than 
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totipotent cells. It can give rise to every cell of the organism, except the trophoblasts of the 
placenta. Most stem cells fall into the category of multipotent stem cells which are dividing 
cells with only limited self-renewal capacity and which can differentiate into at least two 
different cell lineages (Weiss et al., 1996; McKay, 1997; Gage, 2000). They are usually 
defined by the organ from which they are derived or by from where they are observed in 
vivo. Lineage-specific precursors/progenitors are cells which are restricted to one distinct 
lineage (e.g., neuronal, astroglial, glial, oligodendroglial). Together, CNS stem cells and all 
precursor/progenitor cell-types are broadly referred to as "precursors". In a more rigorous 
sense, adult CNS "stem cells" exhibit three cardinal features: (1) they are "self-renewing", 
with theoretically boundless capacity to give rise to progeny exactly like themselves; (2) they 
are proliferative, and continue to undergo mitosis; and (3) they are multipotent for all the 
three different neuroectodermal lineages of the CNS, including the numerous neuronal and 
glial subtypes. 
Studying neurogenesis and neural precursor/stem cell biology in the adult CNS has 
two general aims: (1) to understand the fundamental and basic biology of the nervous system, 
and (2) to develop future cell therapy strategies for CNS disorders. From the more 
fundamental perspective, it is important to learn about the normal role and function of 
precursor cells and neurogenesis in the adult CNS, as this information is critical for our 
understanding of brain function during development, adulthood, and in pathology. With 
regard to NSC therapy, it is now known that endogenous stem cells can be stimulated and 
directed towards target areas to initiate "self-repair" in the brain (Lowenstein and Parent, 
1999; Emsley et al., 2005; Goldman, 2005). Also, the possibility to isolate stem cells from 
the brain, and to expand and manipulate them in culture provides a rich source of grafting 
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material for neural transplantation. From what we know already, NSCs isolated from rodent 
and human brains survive and integrate well in the developing and adult, intact and damaged, 
brain and can migrate considerably to reach perturbed/changing brain areas (Emsley et al., 
2005; Goldman, 2005). Whether these stem cells embrace the exact function of the cells they 
replace remains to be determined. 
With respect to CNS therapy, NSCs offer more than being simply a source for cell 
replacement. Firstly, they can produce a multitude of growth and plasticity promoting 
factors which aid cell survival and create a plastic mileu similar to the one present during 
early development. Secondly, they can interact with host microenvironment, re-establish 
homeostasis and rescue/protect host elements in a pathological situation (Ourednik et al., 
2002; Park et al., 2002; Ryu et al., 2004; Pluchino et al., 2005). A better comprehension of 
the above two NSC characteristics might help achieve the goal of disease prevention beyond 
the already evident goals of repairing what is already degenerating or damaged. Indeed, 
maintaining cellular plasticity might be one of the straightforward concepts in 
neuroprotection. The work presented in this dissertation addresses NSC-mediated 
neuroprotection from oxidative stress, and investigates some of the mechanisms underlying 
this phenomenon. 
Oxidative Stress 
Oxygen is necessary for life but is also potentially hazardous. Therefore, an intricate 
system of pro-oxidant and anti-oxidant processes exists in cells to use oxygen efficiently. 
Oxidative stress occurs when an imbalance in the pro-Zantioxidant homeostasis leads to 
unregulated generation of toxic reactive oxygen species (ROS) such as hydrogen peroxide, 
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superoxide, nitric oxide and the highly reactive hydroxyl radicals (Mates and Sanchez-
Jimenez, 1999). In particular, cells in the brain are quite susceptible to ROS toxicity because 
of their high oxygen consumption, relatively low antioxidant levels and low regenerative 
capacity; oxidative stress is now known as an important event which leads to 
neurodegeneration (Andersen, 2004). 
As their name suggests, ROS are very reactive, interacting with a multitude of 
molecules such as lipids, proteins and DNA to initiate neuronal cell death and 
neurodegeneration through an array of pathways. For example, ROS can oxidatively modify 
lipids and result in the formation of compounds such as acrolein and 4-hydroxy-2,3 -nonenal 
(HNE) causing cellular toxicity (Barnham et al., 2004). More specifically, acrolein decreases 
glutamate and glucose uptake, whereas ROS modified HNE causes protein modification 
resulting in inhibition of the neuronal glucose transporter type-3, the glutamate transporter 
GLT-1 as well as Na+-K+ ATPases (Barnham et al., 2004). ROS modified HNE also 
activates c-Jun aminoterminal kinases and mitogen-activated protein kinase (p38) leading to 
apoptosis (Barnham et al., 2004). In terms of proteins, ROS interactions can lead to the 
impairment of enzymes (like glutamine synthase and superoxide dismutase); in terms of 
DNA, they can cause mutations. Furthermore, excessive levels of ROS lead to dysregulation 
of intracellular calcium signaling (as observed in many neurodegenerative conditions) 
inducing the apoptotic cascade (Ermak and Davies, 2002). Also, ROS-induced calcium 
influx causes excitotoxicity which has been implicated in several neurodegenerative 
conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), amytrophic lateral 
sclerosis (ALS) and Huntington's disease (HD) (Ermak and Davies, 2002). 
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Agents which induce oxidative stress such as 1 -methyl-4-phenyl-1,2,3,6, 
tetrahydropyridine (MPTP), rotenone, and 3-nitropropionic acid (3-NP) are able to cause 
neurodegeneration (Beal et al., 1993; Betarbet et al., 2002). In particular, 3-NP is a 
mitochondrial toxin which produces oxidative stress in vitro and in vivo and evokes 
progressive degeneration of striatal neurons leading to behavioral changes similar to those 
accompanying Huntington' disease in humans (Beal et al., 1993). Based on post-mortem 
analysis of human brains which reveal the presence of elevated levels of oxidative damage 
products such as malondialdehyde, 8-hydroxy-deoxyguanosine, 3-nitrotyrosine and HNE in 
areas of degeneration, and the occurrence of increased free radical production in animal 
models, oxidative stress is considered either as a causative event, or a secondary component 
of the cell death cascade in HD and other neurodegenerative diseases (Bowling and Beal, 
1995; Andersen, 2004). For these reasons, in our studies, we used in vitro and in vivo models 
of 3-NP-induced oxidative stress to analyze the behavior of NSCs and their potential to guard 
the host environment from impending neurodegeneration. 
Cells possess an array of endogenous antioxidant defense mechanisms against 
oxidative stress. Among these mechanisms is the presence of various antioxidant enzymes 
such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), as 
well as nonenzymic compounds such as «.-tocopherol (vitamin E), P-carotene, ascorbate 
(vitamin C) which determine the redox potential and ROS concentration within cells (Mates 
and Sanchez-Jimenez, 1999). SOD destroys the free radical superoxide by converting it into 
hydrogen peroxide which then can be detoxified by CAT or GPx. Four SOD subtypes have 
been identified containing either dinuclear copper (Cu)/zinc (Zn), or mononuclear iron (Fe), 
nickel (Ni) or manganese (Mn) co-factors. Recent reports involving SOD knockouts have 
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revealed that Mn-SOD (manganese-superoxide dismutase/SOD2) is essential for life whereas 
the other forms of SOD are not (Macmillan-Crow and Cruthirds, 2001). CAT, on the other 
hand, reacts with hydrogen peroxide to form molecular oxygen and water and thereby 
protects cells from oxidative damage. Similarly, GPx also detoxifies a variety of 
hydroperoxides (including hydrogen peroxide) by utilizing glutathione and protects cells 
against oxidative injury. Furthermore, proteins such as the uncoupling proteins play an 
important role in mildly "uncoupling" the mitochondria to reduce their free radical load and 
consequently protect the cell against oxidant injury (Arsenijevic et al., 2000; Jezek, 2002; 
Mattiasson et al., 2003). 
In many neurodegenerative diseases, the activities of the antioxidant molecules which 
would normally counteract the injurious effects of ROS are reduced or changed making them 
useful indicators of oxidative stress in these conditions. SOD, CAT, and GPx, for example, 
display reduced activities in affected brain regions in AD (Andersen, 2004). PD is 
characterized by reduced levels of the thiol-reducing agent, glutathione, in the substantia 
nigra, including in dopaminergic neurons (Andersen, 2004). SOD activity is reduced in HD 
brains (Borlongan et al., 1996; Browne et al., 1997). Also, mice with SOD2 and GPx 
deficiency have been shown to be more vulnerable to HD-like effects of 3-NP treatment 
(Andreassen et al., 2001; Kim and Chan, 2002). Mutations in Cu, Zn-SOD have been 
demonstrated to be involved in 20% of all familial cases of ALS (Andersen, 2006). Though 
circumstantial, all this evidence taken comprehensively indicates that reduced antioxidant 
potential might contribute to increased oxidative stress present in these diseases. 
Stem cells show therapeutic potential in many neurodegenerative diseases where 
oxidative stress is a prominent entity (Ourednik et al., 2002; Goldman, 2005). Hence, it is 
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important to understand the behavior and potential of NSCs under oxidant stress and their 
cellular and molecular underpinnings before cell-based therapy can be used as a viable 
option. In this context, this dissertation investigates NSC sensitivity and reaction to 3-NP-
induced free radicals and how they relate to the NSC potential to protect the CNS from 
oxidant injury. 
CNS regeneration and NSCs 
It is a common assumption that neurons of the mature mammalian CNS have minimal 
ability to regenerate following injury. In contrast, however, it is known that peripheral 
nerves can regenerate after various types of trauma. The difficulty of CNS neurons to 
regenerate following damage has been attributed principally to the presence of extracellular 
signaling factors which inhibit axonal growth and/or an inability of mature central neurons to 
respond adaptively to damage. 
Associated with the pessimism regarding CNS regeneration, a prevailing dogma is 
that central neuron maturation leads to decreased structural plasticity. Obviously, CNS 
injuries such as stroke, trauma and neurodegenerative processes do not fully reverse 
themselves. However, in recent years there have been several fundamental discoveries which 
indicate that the mature CNS has a greater potential for producing new neurons and retains 
more significant capacity for structural plasticity than previously thought (Alvarez-Buylla 
and Lim, 2004). Examples include the elaboration of neurons from stem cells which 
subsequently integrate into existing neuronal circuitry (Hermann et al., 2005; Muotri et al., 
2005), the sprouting of axons and resulting cortical re-organization (Darian-Smith and 
Brown, 2000), and the activity-dependent remodeling of dendritic spines and synaptic 
plasticity (Xie et al., 2005). Also, it has been demonstrated that axonal sprouting and cellular 
changes occur in the brain following structural injury (Dancause et al., 2005), and that that 
there is a general and systematic cellular response to injury which involves growth factors 
(Connor and Dragunow, 1998). In addition, the mature CNS continues to express a variety 
of molecules required for the formation of neuronal networks during embryonic 
development. These include growth factors, axon guidance molecules, cell-adhesion 
molecules and proteins which all determine cell fate. Although the functional importance of 
most of these molecules in the adult is unknown, their expression pattern goes beyond the 
regions of known neurogenesis, suggesting that the degree of potential network remodeling 
in the mature CNS may be more extensive than generally believed. 
In terms of NSCs and their connection to CNS regeneration and plasticity, acute 
injury can cause attraction of proliferating precursor cells and the differentiation of local, 
dormant progenitor cells into neurons and glia. Hence, NSCs may be one of the components 
of fundamental 'programs' persisting within the CNS throughout life which not only ensure 
normal development, but also maintain homeostasis when perturbations occur. When neural 
progenitors are actually transplanted into the adult CNS, they are able to survive, 
differentiate, and become incorporated. Thus, NSCs not only show therapeutic potential, but 
also can answer basic biology questions regarding cell proliferation and differentiation, 
target-oriented migration in the CNS, neuronal synapse formation, and reaction to injury in 
the brain. In summary, exogenous NSC transplantation or endogenous NSC stimulation can 
be used as a tool to interrogate and explore the abnormal and normal host CNS and revive the 
brain's capacity for self-repair, regeneration and neuroprotection. 
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The concept of "graft-induced host plasticity" 
NSC transplantation has been proposed to help structural and functional recovery of 
the CNS in the following ways: 
(1) replacing dead or dying cells; 
(2) correction of a biochemical deficit by delivering necessary enzymes, 
neurotransmitters or hormones; 
(3) local innervation and reconstruction of neural circuitries resulting in the restoration of 
synaptic transmitter release, and the re-establishment of functional nerve cell 
connections; 
(4) creation of highly growth permissive tissue bridges for axonal regeneration and 
target-oriented guidance of growing axons; 
(5) and as shown recently, by promoting CNS regeneration and protection through 
growth factor secretion and inflammation-induced stimulation of plastic responses 
which improve survival and function of host neurons. 
Already, early reports by Ourednik et al. (1992 and 1995) suggested that fetal neural 
grafts containing germinative cells (stem cells) could elicit a significant regenerative 
response within the host CNS. The idea that NSCs could have been the important carriers and 
mediators of this process was later investigated and confirmed by the same authors 
(Ourednik at al., 2002) and others (Park, Teng et al. 2002; Teng, Lavik et al. 2002; Lu, Jones 
et al. 2003; Ryu, Kim et al. 2004; Yan, Welsh et al. 2004; Pluchino, Zanotti et al. 2005), and 
supports statement (5) above. The report by Ourednik et al (2002) showed that the damaged 
CNS can benefit from transplanted NSCs not only because of cell replacement but also due 
to rescue of dead or dying cells. In particular, the focus of their report was on aging and 
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MPTP affected dopaminergic neurons in the substantia nigra. After transplantation, although 
some NSCs did differentiate into dopaminergic neurons, most remained undifferentiated and 
expressed glial derived neurotrophic factor (GDNF), resulting in the rescue of the non-
apoptotic but dysfunctional tyrosine hydroxylase (TH)-positive cells and finally reconstituted 
the mesostriatal system. Their results thus indicated that the host can benefit from NSC-
derived cell replacement and also importantly the ability of NSCs to alter the 
microenvironment leading to host cell survival. 
These above results have been corroborated by several other studies: NSCs seeded on 
a synthetic biodegradable scaffold and transplanted into the traumatized spinal cord 
significantly reduced the necrosis and initiated functional recovery (Weiss et al., 1996; Teng 
et al., 2002). Also, NSCs constitutively secrete neurotrophic factors and promote extensive 
host axonal growth after spinal cord injury (Lu et al., 2003). In addition, neural stem cells 
can protect against glutamate-induced excitotoxicity and promote survival of injured motor 
neurons through the secretion of neurotrophic factors (Llado et al., 2004). NSCs 
furthermore, have been shown to exert a protective effect on the host brain when proactively 
transplanted into a rodent model of HD (Ryu et al., 2004). And finally, a quite recent report 
showed NSC-mediated neuroprotection through interactions with the immune system 
(Pluchino et al., 2005). Together, these observations lend support to the concept that 
increased host regeneration and resistance, or "graft-induced host plasticity," in addition to 
differentiation and integration of new neurons, can be an important contributor to the 
observed improvements after NSC engraftment. 
However, the mechanisms underlying the observed protective and regenerative 
effects of NSCs remain elusive. They are likely be a replay of basic developmental processes. 
It is now known that many of the molecules active in development also contribute to 
recovery after CNS injury (Connor and Dragunow, 1998; Imitola et al., 2004). Therefore, a 
guiding idea is that the presence of NSCs and their interaction with the surrounding CNS 
environment, post-transplantation, may lead to expression of developmentally important 
molecules, and finally neuroprotection and/or regeneration. 
One group of such developmental molecules are neurotrophic factors like, 
neurotrophic 3,4 & 5 (NT-3, 4 & 5), brain derived neurotrophic factor (BDNF), glial 
derived neurotrophic factor (GDNF), nerve growth factor (NGF), vacular endothelial growth 
factor (VEGF), ciliary neurotrophic factor (CNTF) and others spontaneously expressed by 
neural stem cells (Ourednik et al., 2002; Emsley and Hagg, 2003; Lu et al., 2003; Maurer et 
al., 2003; Imitola et al., 2004; Llado et al., 2004). These factors, found to be playing key 
roles in the observed neuroprotection in our past and present studies (Ourednik et al., 2002), 
will be extensively discussed in the next section. 
Another group of development-related molecules, possibly involved in graft-induced 
host plasticity, is the group of molecules involved in cellular growth and guidance, such as 
components of the extracellular matrix (ECM), cell adhesion molecules, diffusible factors 
such as sonic hedge hog, and bone morphogenic proteins. These molecules may promote 
axonal outgrowth/sprouting and correct targeting towards their post-synaptic counterparts. 
Additionally, they may be involved in signaling leading to cell survival. In terms of the cell 
adhesion molecule LI, by using its over-expression in NSCs in a MPTP-based lesioning 
paradigm, beneficial effects on stem cell migration and survival as well as the recovery of 
dying host dopamine neurons have been found (Ourednik et al., submitted). Thus, molecular 
interactions between stem cells and the adult CNS via adhesion/recognition molecules may 
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play a significant role in helping stem cells recreate/maintain a homeostatic milieu which 
ultimately can lead to cell survival. 
Finally, a third group of molecules, likely to play a role in NSC-mediated 
neuroprotection, are injury-induced cytokines (Lucas et al., 2006). These cytokines are an 
important part of the host immunological reaction after NSC transplantation. Evidence exists 
that these cytokines can enhance host plasticity (Tonelli et al., 2005) and that the suppression 
of these molecules can lead to dampening of the host regenerative response (Bresjanac et al., 
1997). Also, it was recently shown, when neuroinflammation predominates, transplanted 
NSCs can survive recurrent inflammatory episodes by retaining an undifferentiated 
phenotype and the ability to proliferate (Pluchino et al., 2005). The same study also showed 
that the transplanted NSCs, together with resident CNS cells, could persist and exert 
neuroprotective effects in this highly inflamed environment due to a continuous 
communication with inflammatory cells within perivascular niche-like areas. 
Thus, it is reasonable to conjecture that NSC-host interactions, via the 
aforementioned groups of molecules under pathological stress and the resulting graft-induced 
host plasticity, may be a route by which dormant self-repair and neuroprotective cascades of 
the CNS can re-surface. The details of such interactions in the context of the dissertation 
work are discussed in the last section of this chapter. 
Neuroprotection and neuroprotective factors 
"Neuroprotection' is a term used to describe the putative effect of interventions 
protecting the brain from pathological damage. One obvious group of molecules likely to 
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play a key role in NSC-induced host plasticity and neuroprotection (as mentioned in the 
previous section) is the group of trophic and neuroprotective factors. 
Various neuroprotective factors such as BDNF, NGF, NT-3,4,5, GDNF, CNTF and 
VEGF influence a wide range of cell functions in the developing, mature and injured nervous 
system. It has become increasingly clear that these factors do not have a single function but 
in fact exert many regulatory and protective effects on various type of central and peripheral 
neurons (Barde, 1989; Gomazkov, 2005; Levy et al., 2005). It has been proposed that 
growing axons compete for limited amounts of neurotrophic factors produced by target 
tissues. Neurons, failing to obtain a sufficient quantity of the necessary neurotrophic factor, 
die by a process of programmed cell death thus regulating the number of neurons and 
neuronal connections within the developing CNS (Johnson et al., 1989). The neurotrophic 
factor family has been also been proposed to play a role in the protection of specific types of 
neurons by suppressing the expression of "suicide genes" which, when activated, induce 
apoptosis (Talapatra and Thompson, 2001; Biswas and Greene, 2002). In other words, when 
the level of neurotrophic factors falls below the level required to suppress activation of 
"suicide genes", transcriptional processes may initiate apoptosis. 
The implications of trophic support deficits in the adult mature CNS are still unclear. 
If mature neurons still depend on the presence of neurotrophic factors for survival, then the 
reduction in neurotrophic factors, causing loss of transcriptional suppression of apoptosis, 
may result in the neuronal atrophy observed during aging or neurodegeneration. A theme of 
ongoing research is to determine whether members of the neurotrophic factor family have 
roles in preventing/and or reducing neuronal death/atrophy occurring in neurodegenerative 
disorders such as PD, AD, HD or ALS. Indeed, it has been shown that neurotrophic factors 
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have the potential to protect diseased and injured neurons from dying, and to induce neuronal 
sprouting and increase neuronal metabolism and function (Connor and Dragunow, 1998). 
One of the important areas of current research then is to identify potential ways to deliver 
neurotrophic factors to selectively vulnerable regions of the CNS so as to restore and 
maintain neuronal function. In this vein, in terms of stem cell therapy, it has been 
demonstrated that NSCs can express neuroprotective substances, spontaneously or after 
genetic modification, such as VEGF, CNTF, GDNF, NT-3, BDNF or stem cell derived 
neural stem/progenitor supporting factor (SDNSF) (Maurer et al., 2003; Toda et al., 2003; 
Imitola et al., 2004) and promote host cell survival, making them even more attractive as 
candidates to treat CNS disorders. The following sections provide information on CNTF and 
VEGF, the major neurotrophic factors which were found to be contributing to NSC-mediated 
neuroprotection in the present dissertation. 
Ciliary neurotrophic factor (CNTF) 
Early studies identified CNTF as a trophic factor which supports chick embryonic 
ciliary ganglionic cells (Adler et al., 1979; Lin et al., 1989) from which it derives its name. 
The cloning and sequencing of CNTF after its discovery revealed that it is part of a cytokine 
family that includes more generally acting cytokines such as leukemia inhibitory factor (LIF) 
and interleukin-6 (IL-6) (Lin et al., 1989). Although involved in neuronal differentiation 
processes in vitro, CNTF is primarily considered as a lesion factor because of the lack of a 
signal peptide in the CNTF gene and its immunohistochemically determined cytosolic 
location (Ip and Yancopoulos, 1996). 
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Expression-wise, CNTF is restricted to the Schwann cells in the peripheral and 
astrocytes in the central nervous system and it is now well established that a wide variety of 
central and peripheral neurons respond to CNTF (Ip and Yancopoulos, 1996; Schuster et al., 
2003). Studies show that CNTF is important for the survival of motor neurons (Holtmann et 
al., 2005) and in preventing retrograde cell death of neurons in thalamic nuclei (Clatterbuck 
et al., 1993). CNTF can also enhance the survival of sensory, hippocampal, and cerebellar 
neurons (Larkfors et al., 1994; Semkova et al., 1999; van Adel et al., 2005), and protect 
retinal neurons and endothelial cells from oxidative stress (Koh, 2002; Yu et al., 2004). In 
addition, CNTF is known to slow the progress of motor neuropathy (Sagot et al., 1995), and 
has been shown to have neuroprotective effects in different models of HD (Alberch et al., 
2004). With respect to HD, CNTF can protect striatal neurons in vitro (Petersen and 
Brundin, 1999) and in vivo in rodent and monkey models (Emerich et al., 1997; Emerich, 
2004; Emerich and Winn, 2004). Also, CNTF-treated human NSC transplants improved 
motor function in a rodent model of HD (McBride et al., 2004). Furthermore, a study using 
polymer-encapsulated cells engineered to secrete human CNTF in human HD patients is 
ongoing (Bloch et al., 2004). The ability of CNTF to resist oxidative stress by stimulating 
the JAK/STAT and MAPK pathways and promote cell survival (De-Fraja et al., 2000; 
Kuroda et al., 2001; Kaur et al., 2005) may be contributing to these HD effects mentioned 
above. 
In addition to neurons, there are also non-neuronal cells that respond to CNTF. For 
example, CNTF is involved in the survival and maturation of oligodendrocytes (Linker et al., 
2002). It is also known to be involved in the maturation, proliferation, differentiation of 
astrocytes and is regarded as one of the signals that leading to astrocyte activation following 
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a CNS lesion (Ip and Yancopoulos, 1996). Even NSCs can respond to CNTF. Recently, it 
was shown that endogenous and exogenous CNTF enhance forebrain neurogenesis in adult 
mice (Emsley and Hagg, 2003). Thus all these cell types have the ability to respond to 
CNTF which is made available as a part of a series of complex events occurring after injury, 
making it an important cell survival and neuroprotective factor. 
Vascular endothelial growth factor (VEGF) 
VEGF was originally discovered as an endothelial-specific growth factor. It was 
discovered as vascular permeability factor (VPF) by Dvorak and colleagues in 1983 (Senger 
et al., 1983) and then termed vascular endothelial growth factor (VEGF) after the cloning of 
its gene by Ferrara and coworkers in 1989 (Ferrara and Henzel, 1989). Since then 
insurmountable evidence has been presented that VEGF/VPF is a major player in 
angiogenesis during development and in pathology (Ruhrberg, 2003). Recent observations, 
though, indicate that VEGF also has direct effects on neurons and glial cells, and stimulates 
their growth, and survival (Rosenstein and Krum, 2004; Storkebaum et al., 2004). 
Furthermore, VEGF has also been found to be an autocrine survival factor for embryonic 
stem cells (Brusselmans et al., 2005) and also be involved in the regulation of neurogenesis 
and learning in the hippocampus (Cao et al., 2004). Because of these pleiotropic effects, 
VEGF has now been implicated in several neurological disorders such as leukomalacia, 
stroke, neurodegeneration, cerebral and spinal trauma, ischemic and diabetic neuropathy, and 
nerve regeneration. 
The VEGF gene contains a hypoxia response element that is essential for binding 
hypoxia inducible factor (HIF-1) which is a transcription factor serving as an oxygen sensor 
(Semenza, 2000). During development, transient expression of VEGF, possibly by the 
neuroepithelium and perinatal neurons (Ogunshola et al., 2000), may regulate hypoxia-driven 
angiogenesis so that vessel formation is matched to oxygen and metabolic demand. In the 
mature brain, angiogenesis occurs only after injury and it is now well known that ischemic or 
implantation injuries cause an up-regulation of VEGF and its receptors in neurons and 
astrocytes (Rosenstein and Krum, 2004; Storkebaum et al., 2004). Thus, it is possible that 
nervous system trauma may promote re-emergence of certain developmental cellular events 
strongly influenced by VEGF leading to a process of physiological repair by normalizing 
vascular supply and metabolic demand. During this process of normalization, VEGF, by 
increasing vascular bed and oxygen tension, may have other, perhaps indirect, effects on non­
vascular cell types in the neuropil. In this context, both neuronal and glial cells have been 
shown to possess VEGF receptors (Sondell et al., 2000; Krum and Khaibullina, 2003; 
Rosenstein et al., 2003) and it is hypothesized that VEGF may help orderly developmental 
patterning or reparation of vessels and neurites, under normal and pathological conditions, by 
communication with chemical determinants of neuritic and vascular growth and motility. It 
is also becoming increasingly apparent that VEGF may carry out multiple repair functions in 
the CNS and PNS which include angiogenic, blood brain barrier (BBB) permeabilizing, 
neurotrophic, gliotrophic, and anti-apoptotic actions (Rosenstein and Krum, 2004; 
Storkebaum et al., 2004). Other growth factors such as BDNF and GDNF may support 
neural growth and survival, but only VEGF has the added ability to affect the physiology of 
the extracellular space where neural cells function. Therefore, VEGF can no longer be 
characterized solely as an endothelial mitogen as its nervous system effects may be quite 
broad. Furthermore, in terms of resistance to oxidative stress, VEGF is known to be 
regulated by cellular redox (Maulik, 2002; Schafer et al., 2003; Eyries et al., 2004) and can 
up-regulate or modulate the antioxidant enzyme SOD2 (Abid et al., 2001; Abid et al., 2004). 
Thus, by virtue of its strong expression, VEGF could contribute to brain repair, regeneration, 
and neuroprotection by initiating basic cellular cascades, and play a significant role 
extending beyond simply blood vessel growth. 
NSC interactions with its local environment 
The potential of stem cells today relies upon removing them from their natural 
habitat, expanding them in culture, and placing them into a foreign tissue environment. 
Hence, it is essential to understand how stem cells interact with their extracellular 
microenvironment, the so called stem cell "niche", to establish and maintain their properties 
and therapeutic effects. Niche is a word originally coined in ecology, and is a definition of 
where the cell lives, what it does and how it communicates with its environment. As 
mentioned before in the research objective of this dissertation, it is being realized that once 
the NSCs engraft into the host tissue they are engaged in constant crosstalk with the 
extracellular niche that they inhabit (Imitola et al., 2004; Ourednik and Ourednik, 2005). 
This constant and reciprocal communication between NSCs and their surrounding milieu in 
vivo, leads to proliferation, migration, differentiation, repair, protection and other effects. 
Thus the local microenvironment in which a stem cell resides regulates its behavior and fate. 
For example, it was shown that adult neural stem cells produced neurons when transplanted 
into the neurogenic zone of the hippocampus, but produced astrocytes in the environment of 
the spinal cord (Song et al., 2002a; Song et al., 2002b) . In this study, further investigation 
showed that a specific component of the local environment, the regional astrocytes of the 
hippocampus, were capable of instructing these stem cells to adopt a neuronal fate in vitro 
(Song et al., 2002a). In addition to the regional differences within the nervous system, the 
microenvironment encountered by the stem cell may vary as a function of age of the host 
organism. Similarly, the alteration of the niche by injury, drugs or other circumstances is 
likely to affect the ability of transplanted stem cells to survive, integrate into the circuitry, 
protect, differentiate, and migrate. Just as the surrounding host microenvironment affects the 
fate of stem cells, transplanted cells similarly can also act to influence and alter neighbouring 
host cells. Stem cells, via soluble- or contact-mediated factors, affect the activity or resilency 
of damaged host cells. Therefore, teasing apart and understanding these interactions between 
the stem cell and its environment poses a major challenge that must be faced in order to 
develop realistic cell therapies. 
With regard to NSC-host cell cross-talk, stem cells in vivo are likely to be influenced 
by a multitude of signals originating from the many neighboring cell types in their 
environment. For example in the subventricular zone, where neurogenesis exists throughout 
life, interactions between neural stem cells, ependymal cells, astrocytes, blood vessels and 
their lining endothelial cells are known to be important in its maintainence and functionality 
(Alvarez-Buylla and Lim, 2004). Similarly in NSC niches created after transplantation, cells 
such as astrocytes, endothelial cells, microglial cells and neurons present in the local 
microenvironment may all be important in NSC-host communication (Aarum et al., 2003; 
Wurmser et al., 2004). These cell-cell interactions may be mediated via direct contact, extra 
cellular matrix (ECM), diffusible molecules such as trophic factors and sonic hedgehog, or 
immune response and inflammation (Alvarez-Buylla and Lim, 2004; Imitola et al., 2004; 
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Ourednik and Ourednik, 2005), and contribute to cell differentiation, regeneration and 
neuroprotection after NSC transplantation. 
In the context of cellular interactions in the NSC niche, there are several recent 
reports which suggest that there is a reciprocal communication between the endothelial and 
NSC microenvironments (Louissaint et al., 2002; Cao et al., 2004; Schanzer et al., 2004; 
Shen et al., 2004). It has now been established that the brain distribution of NSCs is not 
random, but rather exists in close association with blood vessels in vascular niche's (Palmer 
et al., 2000; Zhang et al., 2003; Wurmser et al., 2004). This location places NSCs in close 
proximity to endothelial cells which line blood vessels facilitating communication between 
these two cell types. Also, endothelial cells can regulate proliferation and the conversion of 
NSCs to neurons in vitro (Palmer et al., 2000; Shen et al., 2004). Additionally, recent 
evidence suggests that endothelial cell-derived VEGF, a hypoxia inducible molecule 
promoting angiogenesis, also has neurotrophic effects (Rosenstein and Krum, 2004; 
Storkebaum et al., 2004). VEGF also promotes neurogenic effects on neuronal progenitors 
(Jin et al., 2002; Cao et al., 2004; Schanzer et al., 2004; Shen et al., 2004) and has been found 
to be a chemo-attractant for NSCs (Zhang et al., 2003). Chapter III includes data and 
discussion of how endothelial cell-NSC interactions can be important in attaining 
neuroprotection from chemically induced oxidative stress. 
Another important component of stem cell niches are astrocytes (Doetsch, 2003). 
Astrocytes are uniquely poised to act as sensors and regulators in the niche. Their 
meandering processes contact all niche cell types, their end feet terminate on the basal lamina 
of blood vessels and also, they are extensively coupled by gap junctions. Hence they can 
detect alterations, and also initiate as well as promote cellular communication in the niche. 
In addition, they are vast repositories of several trophic and neuroprotective factors (Ridet et 
al., 1997; Svendsen, 2002; Horner and Palmer, 2003). Furthermore, astrocytes are known to 
promote the proliferative and neurogenic abilities of NSCs (Song et al., 2002a). In this 
thesis, we elucidate how NSC-astrocyte communication can contribute to host cell survival 
after transplantation. 
Taken together, these findings imply that it is the combination of the intrinsic 
characteristics of stem cells and their microenvironment which shapes them and their 
potential. After transplantation, a consortium of such factors via NSC-host interactions may 
result in the deployment of appropriate defenses (such as neuroprotective factor production 
and anti-oxidant up-regulation as shown in this dissertation), and later in the modulation of 
gene transcription, thus determining the fate of both donor and host cells. Thus, in order to 
find realistic NSC-based therapies, biologists will need to understand how stem cells and 
their neighbours depend on each other for survival and then test how far a system's 
equilibrium can be pushed before stem cells are wiped out or turn cancerous. In this 
dissertation, we focus on detailing the neuroprotective ability of NSCs and the 
molecular/cellular nature of graft-host interactions underlying this neuroprotection with 
regard to oxidative stress. 
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CHAPTER II. INCREASED "VIGILANCE" OF ANTIOXIDANT 
MECHANISMS IN NEURAL STEM CELLS POTENTIATES THEIR 
CAPABILITY TO RESIST OXIDATIVE STRESS 
LALITHA MADHAVAN, VACLAV OUREDNIK, AND JITKA OUREDNIK 
A paper accepted for publication in Stem cells 
ABSTRACT 
Although the potential value of transplanted and endogenous neural stem cells 
(NSCs) for the treatment of the impaired central nervous system (CNS) has widely been 
accepted, almost nothing is known about their sensitivity to the hostile microenvironment in 
comparison to surrounding, more mature cell populations. Since many neuropathological 
insults are accompanied by oxidative stress, this report compared the alertness of antioxidant 
defense mechanisms and cell survival in NSCs and postmitotic neural progenitors (PNPs). 
Both, primary and immortalized cells were analyzed. At steady-state, NSCs distinguished 
themselves in their basal mitochondrial metabolism from PNPs by their lower reactive 
oxygen species (ROS) levels and higher expression of the key antioxidant enzymes UCP2 
and GPx. Following exposure to the mitochondrial toxin 3-nitropropionic acid (3-NP), PNP 
cultures were marked by rapidly decreasing mitochondrial activity and increasing ROS 
content, both entailing complete cell loss. NSCs, in contrast, reacted by fast up-regulation of 
UCP2, GPx, and SOD2 and successfully recovered from an initial deterioration. This 
recovery could be abolished by specific antioxidant inhibition. Similar differences between 
NSCs and PNPs regarding redox control efficiency were detected in both primary and 
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immortalized cells. Our first in vivo data from the subventricular stem cell niche of the adult 
mouse forebrain corroborated the above observations and revealed strong baseline expression 
of UCP2 and GPx in the resident, proliferating NSCs. Thus, an increased "vigilance" of 
antioxidant mechanisms might represent an innate characteristic of NSCs, which not only 
defines their cell fate, but also helps them to encounter oxidative stress in diseased CNS. 
INTRODUCTION 
The restorative potential of NSCs is based on their abilities to provide cell 
replacement, serve as vehicles for gene therapy, but also, and importantly, on their capacity 
to stimulate reparative responses in the diseased host while promoting re-establishment of 
homeostasis [1-3]. During these events, NSCs and their progeny, together with all the other, 
more mature cell types, become exposed to the hostile environment of the diseased central 
nervous system (CNS). Although many investigations are addressing the deteriorating 
behavior of the mature neurons and glia in such conditions, interestingly, almost nothing is 
known about the vulnerability and the response of the NSCs which, frequently, appear to 
better resist environmental stress [4, 5], 
Oxygen is necessary for life but, paradoxically, its metabolism produces reactive 
oxygen species (ROS) as by-products highly toxic to cells. Because of its elevated metabolic 
rate, high oxygen consumption, and relatively reduced capacity for cellular regeneration 
compared with other organs, the brain is believed to be particularly susceptible to the 
damaging effects of ROS. This becomes evident in diseases such as Parkinson's disease or 
Huntington's disease, where various indices of ROS damage have been reported within the 
specific brain regions that undergo selective neurodegeneration. To make matters worse, 
although mammalian cells have evolved several resistance and repair mechanisms to deal 
with oxidative stress and the associated damage, the activities of various antioxidant defense 
molecules that would normally counteract the injurious effects of ROS are reduced in the 
brain [6 and cit. herein]. This is particularly true for the enzymes superoxide dismutase 
(SOD), catalase (CAT), and glutathione peroxidase (GPx). 
In regard to stem cells, the maintenance of a balance between self-renewal and 
differentiation is pivotal for their function in development, tissue repair, and homeostasis. In 
this context, a new role of the cellular redox state control has been recognized, affecting 
multiple processes related to cell proliferation and differentiation [7], The redox potential and 
the concentrations of free radicals in cells are determined by a balance between their rates of 
production and clearance and are controlled by various antioxidant compounds like SOD, 
GPx, and CAT. Moreover, uncoupling of the mitochondrial respiratory chain by proton 
transporters like the uncoupling proteins (UCPs) reduces free radical production and 
consequently regulates the cellular redox state [8]. The latter's control may also depend on 
the convergence of different signaling pathways, while its changes may, in turn, influence 
processes controlling self-renewal and differentiation. Thus, as demonstrated recently, the 
degree of cellular oxidation/reduction in progenitor cells can be altered by growth factor 
signaling. Depending on the nature of the signaling molecules, it can render the progenitors 
more reduced or oxidized [9]. In the present study, we therefore hypothesized that NSCs and 
their postmitotic progeny differ in their free radical household to an extent that also changes 
their ability to resist oxidative stress. This should be reflected, among others, in distinctive 
expression patterns of their antioxidant enzymes. 
To explore this thought, we examined cultured NSCs and their 7-day-differentiated 
progeny (postmitotic neural progenitors or PNPs) and compared 1) their mitochondrial 
activities and ROS levels at steady-state and after exposure to the mitochondrial toxin 3-
nitropropionic acid (3-NP), and 2) the corresponding expression levels of antioxidant 
molecules and their importance in the response to 3-NP intoxication. Two types of NSCs and 
PNPs often employed in current stem cell research were examined: primary NSCs isolated 
from the subventricular zone (SVZ) of newborn mice and the immortalized NSC clone CI 7.2 
[10,11] successfully used in our previous studies of NSC-mediated rescue of neurons [5]. 
Assessed were their cellular characteristics relating to redox modulation and cell viability, 
such as mitochondrial activity, concentration of free radicals, ratios of surviving and 
apoptotic cells, and intensity of cell proliferation. Next, we analyzed the expression of 
antioxidative enzymes, focusing on the four key modulators UCP2, GPx, manganese-
containing mitochondrial superoxide dismutase (Mn-SOD or SOD2), and CAT [8,12,13]. 
This report also includes our pilot immunohistochemical data pertaining to steady-
state expression of antioxidant modulators in the subventricular stem cell niche in adult 
mouse brains. This data will serve as baseline in future studies addressing the vulnerability of 
endogenous NSCs to 3-NP-induced oxidative stress. 
MATERIALS AND METHODS 
Cell Cultures 
Primary cells NSCs isolated from the subventricular zone of newborn C57BL/6 mice were 
grown under standard conditions in uncoated dishes and serum-free Neurobasal medium 
supplemented with 2% B27 (NB27), 20ng/ml epidermal growth factor (EGF), 10ng/ml basic 
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fibroblast growth factor (bFGF), and S^ig/ml heparin. After 7 and 14 days, primary and 
secondary neurosphere cultures were split and plated at 104cells/ml in NB27 containing EGF, 
bFGF, and heparin to allow formation of tertiary neurospheres. The latter were used for all 
the experiments regarding proliferating NSCs, or differentiated in culture on poly-L-lysine 
for another 7 days without growth factors but in presence of 1% FBS for the derivation of 
PNPs. 
Immortalized cells To match the growth conditions of the primary cells, immortalized cells 
(clone CI7.2 [10]) were grown in serum-free DMEM/F12 medium supplemented with N2, 
50 units/ml penicillin and 50 pg/ml streptomycin, heparin (8pg/ml), bFGF (20 ng/ml) and 
EGF (10 ng/ml) as described [14]. Only early (1-3) passage stocks of the originally 
immortalized cells were used for the preparation of tertiary neurospheres. To derive PNPs, 
the latter were grown on poly-L-lysine without growth factors and in presence of 1% FBS. 
All cells were grown in a standard humidified incubator at 37 °C. The state of cell 
differentiation from tertiary neurospheres was monitored by immunodetection of Ki-67 and 
nestin, both markers for proliferating and immature cells (Fig. lAa-h), class III-(3-tubulin 
(Tuj-1; neuronal marker, Fig. 1A i-1), and glial fibrillary acidic protein (GFAP; glial marker, 
Fig. lAm-p). 
Induction of oxidative stress in vitro 
Cultures of NSCs and PNPs at comparable cell densities (2xl04 cells per well) were treated 
with 3-NP (0.05 mM) for 24 hrs and assayed for the next 5 days in vitro (5 DIVs, i.e., 120 
hrs). 
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Mitochondrial activity 
The colorimetric 4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay 
was used to measure mitochondrial functionality in cells [15]. Briefly, cells were incubated 
with 0.25 mg/ml MTT for 3 hrs at 37 °C and mitochondrial enzyme activity measured in 
culture supematants in a spectrophotometer (Molecular Devices, Sunnyvale, CA) at 570 nm, 
with a reference wavelength of 630 nm. 
ROS levels 
The 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) 
fluorescence assay [16] was applied to measure the levels of free radicals in cells. CM-
H2DCFDA was added at 10 |_iM for 45 min to 3-NP treated cells (during the last 45 min of 
exposure) and to control cultures. Then, the cells were washed with phosphate buffer saline 
(PBS, 0.1 M, pH 7.2), and fluorescence recorded at a wavelength of 485 nm (excitation) and 
535 nm (emission). 
Apoptosis 
Cultures exposed to 3-NP for 24 hr were fixed in 4% paraformaldehyde (PFA) and incubated 
with the Hoechst dye 33342(10 ng/ml) for 3 min in the dark. Using UV illumination, a DAPI 
filter, and a 40x objective, fluorescent (apoptotic) cells were evaluated in 15-20 visual fields 
with a Zeiss Axioplan-2 microscope and the percentage of apoptotic cells determined. 
Inhibition of antioxidant enzymes 
In order to assess their direct relevance in the cellular anti-oxidative response, the enzymes 
UCP2, GPx, and SOD2 that showed significant differences in their expression levels at 
steady-state and after a 3-NP challenge were inhibited with guanosine 5' diphosphate (GDP) 
[17], mercaptosuccinic acid (MS) [18], and dethylthiocarbamate (DETC) [19], respectively. 
The inhibitors were added to cultures 1 hour prior to 3-NP and left for the same duration as 
the toxin, or to 3-NP-free controls over the same culture period. 
Immunocytochemistry in vitro 
Cells grown on poly-L-lysine (0.1 mg/ml)-coated coverslips were fixed with 4% PFA and 
rinsed with PBS. Primary antibodies were diluted in blocking solution (5% goat serum 
supplemented with 0.2% BSA, 0.1% Triton X-100 in PBS) and preparations incubated 
overnight at 4°C. Specific binding was then revealed with the appropriate secondary 
antibodies conjugated to Alexa 488, 594 or 647 and diluted 1:500. 
The following markers were used: For NSCs - nestin (1:1000), Musashi (1:500) and 
Ki-67 (1:500); for PNPs - Tuj-1 (1:500) as neuronal marker and GFAP (1:1000) as astroglial 
marker. Antibodies against UCP2, GPx, and SOD2 were diluted 1:200, 1:500, and 1:1000, 
respectively. Stains omitting primary or secondary antibodies and recordings through non­
specific filters were used as signal-specificity controls. 
Histology and immunohistochemistiy of brain sections 
Adult, 16-week-old C57BL/6 mice were perfused with 4% PFA under deep pentobarbital 
anesthesia. The brains were postfixed in the same fixative for 24 hours, processed for routine 
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cryostat sectioning, and 20-^m-thick serial coronal sections collected, dehydrated sections 
were blocked and immunostained with antibodies against UCP2 (1:100), Gpx (1:250), nestin 
(1:500), Ki-67 (1:250) and Musashi (1:2500) using the same conditions as for the cell 
cultures described above. Stains occurred in coronal sections from levels 25-30 according to 
the stereotactic atlas of the mouse brain by Sidman et al. [20]. All animals were housed and 
maintained at Iowa State University and all animal procedures carried out were approved by 
the Iowa State University Committee on Animal care and adhered to NIH guidelines (Public 
Health Service Policy on Humane Care and Use of Laboratory Animals, 2002). 
Western blotting 
Cells were harvested, washed with ice-cold Ca2+-free PBS and resuspended in 2 ml of 
homogenization buffer (20 mM Tris-HCl, pH 8.0, 10 mM EOT A, 2mM EDTA, 2 mM 
dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 25 ng/ml aprotinin, and 10 ng/ml 
leupeptin). Suspensions were sonicated for 10 s, centrifuged at 13,000g for 30 min, and the 
supematants collected as whole cell lysate fractions. Samples containing equal amounts of 
protein were separated by 15% SDS-PAGE and blotted onto nitrocellulose membranes. After 
blocking of nonspecific binding sites with blocking reagent, antioxidant proteins were 
revealed by incubation of the membranes with antibodies against UCP2 (1:200), GPx 
(1:1000), SOD2 (1:2000), and CAT (1:1000) overnight at 4°C. Secondary antibodies 
conjugated to horseradish peroxidase (1:2000) were applied to visualize bound proteins in 
Amersham's ECL chemiluminescence assay. Equal protein loading was confirmed by re-
probing of the membranes for (3-tubulin. 
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Densitometry 
Western blots were scanned and the NIH software Image J, version 1.34, used to quantify the 
densities of immunoreactive bands by calculating the area under the peak curves 
corresponding to UCP2, GPx, SOD2, and CAT. 
Chemicals 
3-NP, GDP, DETC, and MS were obtained from Sigma (St. Louis, MO). CM-H2DCFDA, 
MTT, and Hoechst 33342 stain were obtained from Molecular Probes (Eugene, OR). 
Dulbecco's modified Eagle medium (DMEM), Neurobasal medium (NB), Dulbecco's 
modified Eagle medium with F12 supplement (DMEM-F12), fetal bovine serum (FBS), L-
glutamine, penicillin/streptomycin, N2 supplement, B27 supplement, EGF, bFGF, and 
heparin were purchased from Invitrogen (Carlsbad, CA). Primary antibodies against nestin, 
UCP2, and GPx were received from Chemicon (Temecula, CA), anti-SOD2 from Upstate 
(Lake Placid, NY), anti-CAT from Genetex (San Antonio, TX), anti-Musashi from CeMines 
(Evergreen, CO), anti-Ki-67 from Dakocytomation (Carpinteria, CA), Tuj-1 from Covance 
(Berkeley, CA), and anti- GFAP from Sigma. All secondary antibodies were purchased from 
Molecular Probes. 
Data analysis and statistics 
All data are expressed as means ± S.E.M. and derived from at least 3 separate experiments. 
Data analysis was performed using Prism 4 software (GraphPad Software, San Diego, CA). 
Data were first analyzed using one-way analysis of variance (ANOVA). Then, either 
Dunnett's test was applied in the case of multiple comparisons with control, or Bonferroni's 
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test for multiple comparisons between treatment groups and the statistical significance 
determined. Single comparisons were performed by Student's t test or Welch-corrected 
unpaired t test where appropriate. Differences were accepted as significant atp< 0.05 or less. 
RESULTS 
Steady-state characteristics of NSCs and PNPs related to redox state and cell survival in 
vitro 
To obtain reference points for our study of 3-NP-induced oxidative stress in NSCs 
and PNPs, we first needed to assess basal levels of the evaluated cellular modalities, namely, 
mitochondrial activity (MTT assay), ROS production (CM-H%DCFDA oxidation), and 
apoptosis (Hoechst-33342 staining). 
In NSC cultures, about 80% of the cells proliferated (Fig. lAab and Bd, white 
columns) and expressed nestin (Fig. lAef), but no Tuj-1 and GFAP characterizing more 
differentiated cell types (Fig. lAijmn). After differentiation for 7 days, PNPs were 
characterized by less than 5% of dividing cells (Fig. lAcd and Bd, hatched columns), had 
lost their nestin positivity (Fig. lAgh) and expressed neuronal and glial markers (Fig. 
lAklop). 
Striking differences in mitochondrial activity and intracellular ROS levels between 
NSCs and PNPs were recorded, whether primary or immortalized. NSCs (Fig. IB, white 
columns) demonstrated a significantly (p<0.05) greater steady-state mitochondrial activity 
(Fig. IBa) than their postmitotic counterparts (hatched columns) and lower ROS production 
(Fig. lBc). Correspondingly, PNPs also counted higher numbers of apoptotic cells (Fig. 
lBb). These data were the first indicators supporting our hypothesis that NSCs and PNPs 
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differ in their basal redox states, with the NSCs being better equipped to control intracellular 
ROS and resist oxidative stress. 
A comparison of the analyzed parameters between the primary and immortalized cells 
revealed subtle cell type-specific differences (compare left and right plots in each panel a-d 
in Fig. IB), although the same trend of their changes between NSCs (white columns) and 
PNPs (hatched columns) prevailed. Possible reasons for this finding will be discussed. 
Response of NSCs and PNPs to 3-NP-induced oxidative stress 
After collection of the data pertaining to steady-state ROS metabolism, apoptosis, and 
cell proliferation in NSCs and PNPs, we next investigated their response to the mitochondrial 
toxin 3-NP. 
NSCs No significant changes in NSC number, proliferation, and apoptosis were observed 
at the time of the toxin removal (t=0), although the MTT readings had dropped about 20 - 30 
% below control values (Fig. 2, dashed lines). Cell behavior remained constant during the 
next 24 hours, after which mild deterioration became noticeable. The latter reached a peak at 
about 60-72 hrs post-3-NP, when a spontaneous recovery began, resulting in slightly 
different end values in primary and immortalized cells. While by the end of the 5th 
experimental day (120 hrs), primary NSCs had returned to values of the untreated controls 
(Fig. 2 acegi), immortalized NSCs remained at 75% in their MTT values (Fig. 2b) and also 
remained affected in their proliferative activity (Fig. 2j). Both translated to a reduction of 
20% in their cell numbers (Fig. 2h) and suggested a less efficient control of intracellular 
ROS than in primary NSCs. 
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PNPs The behavior of PNPs in response to 3-NP was radically different from that of the 
NSC cultures and appeared to perpetuate the initial steady-state difference between both 
culture types. Immediately after toxin removal (t=0), PNPs already exhibited obvious 
detrimental changes in all the measured parameters (Fig. 2, solid lines). In primary and 
immortalized PNPs, the considerable initial drop in mitochondrial viability quickly became a 
sigmoid decline bringing it to almost zero at 72 hrs post-3-NP (Fig. 2ab). This drastic decay 
of the cultures was mirrored in an exponential increase in ROS content and numbers of 
apoptotic cells (Fig. 2c-f). A corresponding decrease in cell numbers left hardly any 
surviving cells in the wells (Fig. 2gh), which made changes of intracellular ROS and 
apoptosis after 3 DIVs hardly measurable. 
At all the evaluated times, PNPs were almost completely negative for the nuclear 
proliferation marker Ki-67, irrespective of their treatment with 3-NP (Fig. 2ij). 
Differential expression of antioxidant molecules between NSCs and PNPs during 
steady-state and after 3-NP intoxication 
The main enzymatic responses resulting in ROS detoxification are carried within the 
cells by molecules like GPx, SOD2, and CAT. UCP2, a mitochondrial proton transporter, can 
also help lowering ROS levels by reducing mitochondrial membrane potential [8,21]. Thus, 
part of the contributing reasons explaining the difference in the redox state values between 
NSCs and PNPs were likely to be found in unequal activities of their antioxidant defense 
mechanisms. To explore this hypothesis, we analyzed the expression levels of the above 
enzymes, either in qualitative immunostains of cell cultures (Fig. 3) or quantitatively from 
scans of Western blots (Fig. 4). 
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Steady-state expression of antioxidants Initial qualitative comparison of antioxidant 
steady-state levels between NSCs and PNPs revealed a much stronger expression of UCP2 
and GPx in the former, for both primary and immortalized cells (Fig. 3). In contrast, both 
types of cells showed similar levels of SOD2 and CAT activity (not shown). This result was 
subsequently confirmed and quantified in Western blots as illustrated in Figure 4 (U values). 
3-NP-induced expression of antioxidants Adaptive changes of antioxidant levels during the 
first 60 hours post-3-NP appeared less prominent in PNPs (dashed columns) than in NSCs 
(white columns). In neither of the evaluated enzymes did the PNPs show any significant 
upregulation, compared to their U control values, except in the case of UCP2 after 12 hours 
(p<0.05; Fig. 4a) and some increase in SOD2 at 60 hrs (p<0.06; Fig. 4e) in primary PNPs. 
In contrast to PNPs, NSCs responded to 3-NP with considerable up-regulation of the 
enzymes UCP2 and SOD2 in primary (Fig. 4ae, white columns) and GPx in immortalized 
cells (Fig. 4d, white columns). Thus, in comparison to the steady-state levels (U values), 3-
NP exposure could further increase existing enzymatic differences between NSCs and PNPs 
(Fig. 4a-d) and induced molecules such as SOD2, which did not show any differences at 
steady-state levels (Fig. 4e). 
Inhibition of redox modulators in NSCs and its effects on their response to oxidative 
stress 
In NSCs, the antioxidative enzymes UCP2 and GPx appeared to play a major role in 
steady-state-ROS metabolism and, together with SOD2, were the ones to be most 
prominently up-regulated in their response to oxidative stress. To test the direct functional 
relationship between the changing levels of these enzymes and the resistance of NSCs to 3-
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NP, we inhibited the activity of these molecules with their inhibitors GDP, MS, and DETC, 
respectively. The resulting cellular behavior (Fig. 5, black lines) was then compared to that 
of non-inhibited NSCs and PNPs (Fig. 5, grey dashed and solid lines). In simultaneously 
processed 3-NP-free controls, the application of inhibitors alone did not produce any toxic 
effects (not shown). 
After inhibition of UCP2 and GPx, the viability of primary and immortalized NSCs 
exposed to 3-NP was strongly reduced while a block in SOD2 activity did, interestingly, not 
produce any effects. In contrast to non-inhibited NSCs (Fig. 5, gray dashed line), the ones 
deprived of UCP2 or GPx activity (black solid lines) were unable to recover from the 
neurotoxic effects and they continued to deteriorate throughout the experimental period of 5 
days. Not surprisingly, blocking of all three tested enzymes simultaneously led to the most 
severe deterioration of NSC viability, approaching it to that of the non-inhibited PNPs 
(compare the black and gray solid lines). 
Expression of redox modulators in the SVZ of the mouse brain 
In the in vitro studies described so far, we found that in their ROS household and 
tolerance of oxidative stress, NSCs are characterized by more active antioxidant defense 
mechanisms than more differentiated cell types. Since the largest steady-state differences 
were found in the expression levels of UCP2 and GPx (U values in Fig. 4a-d), we examined 
immunohistochemically the presence of both proteins in the germinative zones of the adult 
mouse brain [22] at coronal levels 25-30 according to reference 20. 
While cells positive for both tested antioxidant molecules were dispersed throughout 
the brain parenchyma, strongly stained cells were predominantly localized within the antero-
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lateral portion of the SVZ (about 5% of the resident cells; Fig. 6, schema j) and in the 
subgranular zone of the dentate gyrus (not shown). Both regions represent the two main stem 
cell niches of the forebrain [23]. 
To characterize these cells, we used the proliferation marker Ki-67 (Fig. 6g-i) and the 
stem cell marker Musashi (Fig. 6a-f and details dl-fl) [24]. Cells positive for these markers 
were consistently characterized by strong expression of UCP2 and GPx. 
DISCUSSION 
Oxidative stress due to excessive presence of ROS is a permanent threat to any cell 
with aerobic metabolism and accompanies many traumatic CNS pathologies and diseases 
like Parkinson's disease and Huntington's disease. Particularly in the brain, where 20% of 
the oxygen consumed by the body is utilized, cells have to rely on a variety of potent 
antioxidant defense mechanisms and a close interaction of glial and neuronal cells for 
constant removal of ROS [12,25-27]. Interestingly, while extensive studies have been 
performed on the mature cell types populating the CNS, almost no data exist about the effects 
of oxidative stress on NSCs and their postmitotic progeny. In the light of the present hopes to 
use these cells for therapeutic transplantation and/or take advantage of their endogenous 
counterparts, the investigation of this issue has become an important necessity and the 
present report is a first step in this direction. 
To be able to realize their therapeutic purpose, grafted and endogenous NSCs have to 
resist the hostile pathological microenvironment as much as or even better than the other host 
cell populations. In the present study, we addressed this possibility by comparing NSCs and 
their PNP counterparts with respect to their steady-state ROS household, cell viability, and 
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expression levels of several key proteins with antioxidative functions, and their changes in 
response to 3-NP-induced oxidative stress. 
By interfering with the mitochondrial electron transfer chain and leading to energy 
depletion, 3-NP exposure results in increased production of ROS like superoxide (O2") and 
hydrogen peroxide (H2O2) [28]. To address both mitochondrial and cytoplasmic antioxidant 
detoxifier mechanisms controlling intracellular accumulation of ROS, we investigated the 
expression of the redox modulators UCP2, GPx, SOD2, and CAT. 
UCP2 belongs to the family of mitochondrial H+ transporters that regulate oxidative 
phosphorylation by increasing the uncoupling of electron transport and ATP formation [8]. 
Recently, UCP2 has been shown to be induced by acute brain injury like stroke and to 
participate in neuroprotection and cellular rescue during MPTP-mediated neuronal damage 
[13,29,30], which made us to include this redox modulator in our investigations. The other 
three antioxidant enzymes, GPx, SOD2, and CAT, are well characterized scavengers of free 
radicals; SOD2 is activated by high levels of superoxide and converts it to H2O2, while the 
cytoplasmic GPx and CAT convert the latter to H2O [27]. 
According to recent literature, it appears that the transcriptome of hematopoietic, 
neural, and embryonic stem cells includes a subset of genes, the products of which not only 
help to define "sternness" but can also provide the cells with higher resistance against 
oxidative stress [31,32]. Moreover, the intracellular redox state of NSCs also appears to 
regulate the cells' balance between their self-renewal, cell differentiation, and apoptosis [9] 
and may therefore require special regulatory attention. The outcome of the present study is a 
concrete example of NSC behavior corroborating the first of these suggestions. 
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Steady-state characteristics Cultured NSCs were found to be by default better equipped to 
control intracellular ROS than PNPs. This was reflected in their significantly higher 
mitochondrial activity, lower ROS content, reduced apoptosis, and in their comparatively 
higher basal levels of UCP2 and GPx. It has been reported that proliferating cells can actually 
produce substantial amounts of ROS endogenously [33]. Our results suggest that the 
maintenance of higher steady-state levels of UCP2 and GPx in stem cells is one of their 
strategies to offset this effect. 
Response to 3-NP treatment We observed that NSCs resisted evoked oxidative stress better 
than the PNPs and were able to recover from its effects within 5 days after the insult. In 
agreement with these findings, NSCs increased substantially their levels of antioxidant 
proteins while the latter remained almost unchanged in PNPs. The disparate response of both 
cell types to oxidative stress suggests, at least in part, an overall higher steady-state 
"vigilance" of redox control mechanisms in NSCs. Their stem cell characteristics, including 
proliferation, appear to be associated with a higher "alertness" of proteins like UCP2 or GPx 
to changes in intracellular ROS levels. Both proteins can decrease the probability of 
mitochondrial permeability transition [34], the release of apoptogenic factors [35], and the 
activation of caspase-3-mediated cell death [36]. GPx has also been shown to protect against 
3-NP-induced apoptosis [37]. Hence, a possible interaction of apoptosis-modulating proteins, 
such as the members of the Bel family, with antioxidant proteins like UCP2 or GPx and the 
ensuing suppression of apoptotic cell death can be one way for cells to counteract the effects 
of oxidative stress. The fact that we did not see any increase in CAT can be attributed to the 
role of GPx as the major source of protection against low levels of ROS and its greater 
affinity for hydrogen peroxide than CAT [27]. 
We propose that, intriguingly, a molecular network helping NSCs maintain stem cell 
status [9,31,32] may also be responsible for enzymatic "priming" in the control of cellular 
homeostasis. In the case of UCP2, GPx, and SOD2, this fact appeared to allow the NSCs to 
react quicker and more efficiently to external insults related to oxidative stress than PNPs 
which were marked by weaker expression and response of all three redox modulators. A 
similar principle, however, may also apply for other stem cell features helping NSCs to 
survive and interact with a pathological environment. Indeed, it has been recently reported 
that NSCs, by definition lacking differentiation markers and MHC molecules on their 
surface, show low immunogenicity and thus escape to a great extent the brain's immune 
response [38,39], 
In the present study, interestingly, primary and immortalized NSCs displayed some 
minor behavioral differences: In primary NSCs, the contents in UCP2 and SOD2 increased 
upon exposure to 3-NP, while both remained unchanged in the immortalized NSCs. The 
latter, on the other hand, up-regulated instead their GPx activity. It has been documented that 
overexpression of the myc gene can cause elevated ROS production in cells and can down-
regulate NF-icB-mediated expression of redox regulators like SOD2 [40,41]. Such myc-
dependent interference with the expression of antioxidants could explain the slightly worse 
values pertaining to cell viability and ROS household in immortalized NSCs when compared 
to those recorded from primary NSCs - both in their steady-state behavior and after a 
challenge with 3-NP. It could also play a role in the differential, 3-NP-induced expression 
patterns of the three tested redox modulators between primary and immortalized NSCs. 
Irrespective of the induction patterns of antioxidants, both primary and immortalized 
NSCs - in comparison with PNPs - showed an equally high resistance to oxidative stress, 
even if their levels of the tested antioxidants differed. This indicates that other existing 
defense mechanisms might help NSCs, in general, to stabilize their redox states. Examples of 
such mechanisms that we are currently investigating are enhanced adaptive controls of nitric 
oxide (NO) production and thiol pools due to proliferation- and wye-mediated permanently 
elevated ROS levels [42-44]. 
Inhibition of the antioxidant response to 3-NP To test the importance of the 3-NP-induced 
enzymes UCP2, GPx, and SOD2 for NSC survival, we inhibited their activity before and 
during the exposure of the cells to the mitochondrial toxin. The blocking of either UCP2 or 
GPx resulted in a substantial reduction in NSC viability and raised ROS levels and numbers 
of apoptotic cells. When all three enzymes were inhibited simultaneously, the NSCs died 
with rapidly increasing ROS levels and decreasing MTT values similarly to PNPs. Thus, 
although we can assume that additional signaling pathways contribute to the resistance of 
NSCs to oxidative stress, the cumulative control of membrane potential and efficient ROS 
clearance appear crucial for their survival and enhanced tolerance. 
We found that the inhibition of SOD2 alone did not have any significant effects on 
the viability of NSCs. Although the steady-state levels of this enzyme were comparable 
between NSCs and PNPs, it was quickly and strongly induced in primary NSCs responding 
to 3-NP. No changes were observed in the case of immortalized NSCs, which could have 
been, as discussed before, the consequence of the inhibitory influence of myc over-expression 
in these cells. These results suggest that SOD2 is not involved in ROS control during steady-
state homeostasis in these cells and that other additional antioxidant mechanisms may have 
compensated for its inhibition during the stress response. Also, UCP2, which is known to be 
stimulated by mitochondrial superoxide, may have played an important role in quenching 
superoxide-induced oxidative stress in the NSCs [45]. 
Steady-state expression of antioxidants in NSCs in vivo Stem cells represent an important 
source of building material in both development and regeneration of the CNS and may very 
well take advantage of the "sternness-defining", enhanced control of their redox state to be 
better prepared than the rest of the brain for the arrival of oxidative stress. This we found 
confirmed in vitro, where NSCs were characterized by more active antioxidant defense 
mechanism than their PNP counterparts. Since the largest differences in steady-state levels of 
antioxidant enzymes between NSCs and PNPs were those of UCP2 and GPx, we performed a 
pilot study of the expression of both enzymes in the stem cell niche [23] of adult mouse 
forebrain. Intriguingly, we found that endogenous NSCs localized in the SVZ and the 
subgranular zone of the dentate gyrus are also characterized by higher steady-state levels of 
UCP-2 and GPx when compared to neural cells in other brain areas. This finding, being in 
harmony with our in vitro results, adds a new and important characteristic to the already 
special nature of neural stem cell niches: they represent a source of cells that, by the nature of 
their stem cell transcriptome, are relatively well equipped to resist oxidative stress and, 
perhaps, other forms of pathological insults as well. A better understanding of such stem cell 
features is therefore likely to have an important impact on our views of CNS development, 
activation of endogenous NSCs during injury, and NSC transplantation. 
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Figure 1 
Steady-state characteristics of NSCs and PNPs related to redox state and cell survival in 
vitro 
[A] Microphotographs comparing the expression of stem cell and postmitotic cell markers in 
NSCs and PNPs. Most of the cultured NSCs (left group of panels) expressed the nuclear 
marker Ki-67, revealing all dividing cells (ab), and nestin, a prototypic marker for 
undifferentiated NSCs (ef). They were, however, negative for cell type-specific markers such 
as the neuronal Tuj-1 (ij) and the astrocytic GFAP (mn). PNPs (right group of panels), on 
the other hand, had lost their Ki-67 and nestin positivity (cd and gh) and began to express 
Tuj-1 and GFAP (kl and op). Bar: 40nm 
[B] Quantitative evaluation of cell culture viability: Mitochondrial activity (MTT values, a), 
levels of free radicals (CM-H2DCFDA reaction, c), number of apoptotic cells (Hoechst 
33342 staining, b), and cell proliferation (anti-Ki-67 immunostaining, d) were compared in 
cultured NSCs (white columns) and PNPs (hatched columns). Both primary and 
immortalized NSCs displayed stronger mitochondrial activity (a), lower ROS content (c) and 
less apoptosis (b) than the corresponding PNPs, indicating their better ROS buffering 
capacity. As expected, about 80-85% of the NSCs was proliferating and stained for the Ki-67 
marker (d), while PNPs remained almost all negative. * p<0.05, *** pO.OOl 
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Figure 2 
Response of NSCs and PNPs to 3-NP-induced oxidative stress After a 24-hr-treatment 
of the cultures with 0.05 mM 3-NP, NSCs (dashed curve) proved to be less susceptible to 
the resulting oxidative stress than PNPs (solid curve).Not only were the initial effects (t=0) 
less pronounced in the NSCs but they also were capable, after transient deterioration between 
36-72 hrs, to recover. This was reflected in time-dependent changes of the cells' 
mitochondrial activity (ab), increasing ROS levels (cd), and numbers of apoptotic cells (ef). 
Interestingly, while primary NSCs recovered completely within the 5-day experimental 
period, mitochondrial activity (b), cell numbers (h), and proliferation (j) of immortalized 
NSCs did not recuperate fully. PNPs (solid line) died within 72 hours (e-h), which was 
accompanied by their rapidly degrading mitochondrial activity and rising ROS levels (a-d). 
While in panels a-h, all values are expressed as percentage of the corresponding controls, in 
panels i and j, the control values referred to are those of Ki-67 labeling indices (percentage of 
labeled cells) in untreated NSC cultures represented by the horizontal lines. 
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Figure 3 
Steady-state expression of the antioxidant molecules UCP2 and GPx in NSCs and PNPs 
in vitro Cultures of NSCs and PNPs were immunostained for their expression of the 
antioxidant molecules UCP2 and GPx. Most (-90%) of primary and immortalized NSCs 
stained intensively for both proteins (Aac and Bac) while their PNP counterparts were only 
weakly labeled (Abd and Bbd). Steady-state expression of SOD2 and CAT showed no 
differences between NSCs and PNPs (not shown). Bars: 20p.m. 
Figure 4 
Western blot analysis of 3-NP-induced differential expression patterns of antioxidant 
molecules in NSCs and PNPs Expression levels of antioxidant molecules (UCP2, GPx, 
SOD2, and CAT) in NSCs and PNPs were evaluated quantitatively in densitometry scans of 
Western blots prepared from whole protein extracts 12 and 60 hrs after treatment of the 
cultures with 3-NP. Quantification was achieved by integration of the area under the 
densitometric peak curve of each protein and the data are plotted in comparison to the 
untreated controls (U). The intensity of the 3-NP-induced changes in the levels of antioxidant 
molecules varied considerably not only between NSCs and PNPs but also between primary 
and immortalized cells. While NSCs (white columns) were characterized by strong 
upregulation of UCP2 and SOD2 (primary; ae), as well as GPx (immortalized; d), no striking 
response to the toxin was found in PNPs (dashed columns). See main text for more details. * 
p< 0.05, ** p< 0.01, *** p< 0.001. 
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Figure 5 
Inhibition of redox modulators in NSCs and its effects on their response to oxidative 
stress A pharmacological block of the redox modulators UCP2, GPx, and SOD2 by GDP, 
MS, and DETC, respectively, led to a drastically increased sensitivity of the proliferating 
NSCs to the detrimental effects of 3-NP. Inhibition occurred either of individual antioxidants 
(A-C) or of all three of them simultaneously (D). In each of the 4 panels, the obtained data 
from the inhibited NSCs (solid black line) pertaining to their mitochondrial viability (ab), 
intracellular ROS levels (cd), and number of apoptotic cells (ef) were compared with 1) non-
inhibited NSCs (gray dashed line) and 2) non-inhibited PNPs (gray solid line). While 
inhibition of UCP2 (A) and GPx (B) resulted in a significant (p<0.05) oxidative damage of 
the NSCs and their decreased viability, the block of SOD2 remained without obvious effects 
(C). The simultaneous inhibition of all three antioxidants led, on the other hand, to a marked 
(p<0.001) deterioration of NSC behavior and approached it to the values of the non-inhibited 
PNPs exposed to 3-NP. See main text for more details. 
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Figure 6 
Expression of redox modulators in the subventricular zone (SVZ) of the mouse brain 
Coronal, 20-pm cryostat sections of adult mouse forebrains were immunostained to reveal 
expression of UCP2 and GPx in neural cells. NSCs were monitored for the presence of the 
stem cell marker musashi (Mus; a-f and details in dl-fl) and the proliferation marker Ki-67 
(g-i). Cells maintaining significant levels of UCP2 and GPx were found mainly within the 
antero-lateral regions of the forebrain SVZ and only rarely within the brain parenchyma 
(white crosses in schema j). Their location overlapped with that of NSCs labeled with Mus 
and Ki-67. See main text for more detail. LV - lateral ventricle, CP - caudoputamen, CC -
corpus callosum, M - midsagittal line. Bars: a-i = 20pm, di-fi - 10pm 
LV CP LV CP 
CC X 
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CHAPTER III. NEUROPROTECTION FROM OXIDATIVE STRESS IN 
THE STEM CELL NICHE: 
CELLULAR NETWORKS AND REGULATION OF ANTIOXIDANT 
EXPRESSION 
LALITHA MADHAVAN, VACLAV OUREDNIK, AND JITKA OUREDNIK 
A paper accepted with revisions by The Journal of Neuroscience 
ABSTRACT 
Recent studies indicate that transplanted neural stem cells (NSCs) can interact with 
the environment of the central nervous system and stimulate protection and regeneration of 
host cells exposed to oxidative stress. To inspect the cellular and molecular bases of this 
phenomenon, we applied 3-nitropropionic acid (3-NP) in vitro (co-cultures of NSCs and 
primary neural cell cultures) and in vivo (NSC-transplanted mice) to induce oxidative stress 
and to investigate NSC-dependent activation of antioxidant mechanisms and cell survival. In 
both models, proactive presence of NSCs significantly improved cell viability by interfering 
with production of free radicals and increasing the expression of neuroprotective factors. In 
vivo, animals grafted with NSCs and treated with 3-NP exhibited reduced behavioral 
symptoms and less severe damage of striatal vessels and cytoarchitecture than sham-
transplanted controls. This amelioration correlated with the distribution pattern of donor cells 
in the host brain and expression of ciliary neurotrophic factor (CNTF) and vascular 
endothelial growth factor (VEGF) in a network of NSCs, local astrocytes, and endothelial 
cells. Intriguingly, both in vitro and in vivo, the enhanced secretion of both factors stimulated 
a robust up-regulation of the antioxidant enzyme superoxide dismutase 2 (SOD2) in neurons 
75 
and resulted in their improved survival. Our findings thus reveal a so far unrecognized 
interaction between NSCs and surrounding neural and non-neural (including endothelial) 
cells accompanying neuroprotection. We illustrate how cellular networks in the niche may, 
through mutual stimulation of growth factor production and activation of antioxidant 
mechanisms, shield the local environment from the arriving impact of oxidative stress. 
INTRODUCTION 
When transferred into the recipient central nervous system (CNS), NSCs become 
tightly embedded within its microenvironment and a dialogue ensues between graft and host 
elements leading to dynamic cellular and molecular changes in both (Sheen et al., 1999; 
Ourednik and Ourednik, 2005). While grafted NSCs can integrate and mature in the 
developing or diseased CNS, a substantial number remains undifferentiated and can become 
important for the "rescue" of chronically impaired host neurons by, e.g., increased production 
of glia-derived neurotrophic factor (GDNF) (Ourednik et al., 2001; Ourednik et al., 2002). 
Therefore, although injury alone stimulates the host microenvironment to release important 
plasticity-modulating substances endogenously (Gall and Isackson, 1989; Hicks et al., 1999), 
their concentration and effects are likely to be substantially modified by interactions of donor 
and host elements (Ourednik et al., 2002; Park et al., 2002). 
The aim of the present study was to examine in vitro and in vivo the nature of the 
interaction between NSCs and the surrounding cells in presence of oxidative stress evoked by 
3-nitropropionic acid (3-NP), an inhibitor of the mitochondrial respiratory complex II (Beal 
et al., 1993; Beal et al., 1995). The central question was, whether NSCs, if added to the 
culture of primary neural cells or grafted into adult brain, could enhance 3-NP resistance in 
both. In our in vitro studies, either primary neuronal/glial cells (PNGs) or primary neurons 
(PNs) were cultured alone or in the presence of NSCs prior to 3-NP treatment. Before and 
after the latter, we monitored cell viability, production of reactive oxygen species (ROS), 
apoptosis, and characterized cell types by immunocytochemistry. In the in vivo model, 
correspondingly, mock-grafted (vehicle or 3T3 fibroblasts) and NSC-grafted mice were 
intoxicated using a modification of the subacute 3-NP lesioning model by Femagut et al. 
(2002). Behavioral tests and immuno-histopathological analyses were used for evaluation in 
comparison to intact and intact/grafted animals. 
Among the many aspects of interaction between NSCs and their cellular environment, 
we focused on intercellular signaling resulting in changed expression of growth factors such 
as brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or vascular 
endothelial growth factor (VEGF). Next, we asked how their presence may have contributed 
to the protective interaction of the participating cells and whether these factors influenced the 
production of a prototypic ROS detoxifier, the manganese-dependent superoxide dismutase 
(MnSOD or SOD2; Mates and Sanchez-Jimenez, 1999). 
We found that NSCs in culture were more resistant to 3-NP than primary cells and 
that their presence prior to toxin exposure enhanced the resistance of postmitotic neural cells 
and enabled them to overcome the induced oxidative stress both in vitro and in vivo. In both 
cases, enhanced production of growth factors was associated with the activation of 
antioxidant mechanisms, as exemplified with SOD2. Particularly intriguing was the intimate 
dialogue between NSCs and their environment, in which not only the NSCs up-regulated 
their production of growth factors in response to 3-NP, but, importantly, they also 
specifically induced a similar behavior in both the surrounding neural (neurons and glia) and 
non-neural (endothelial) cells. 
MATERIAL AND METHODS 
In vitro studies 
Neural stem cells For our in vitro and in vivo studies, we used NSCs isolated from the SVZ of 
newborn C57BL/6 (Harlan, Indianapolis, IN) mouse and labeled with enhanced green fluorescent 
protein (eGFP) using retroviral transduction (Rappa et al., 2001). The cells were grown, under 
standard serum-free conditions in Neurobasal (NB) medium supplemented with B27, 50 units/ml 
penicillin and 50 pg/ml streptomycin, heparin (8 ng/ml), basic fibroblast growth factor (bFGF; 20 
ng/ml) and epidermal growth factor (EGF; 20 ng/ml). 
NIH 3T3 fibroblasts Cells were grown in medium containing Dulbecco's Minimal 
Essential Medium (DMEM) supplemented with 10% FBS, L-glutamine (2 mM), and 50 
units/ml penicillin and 50 pg/ml streptomycin. 
Primary neural cells (PCs) PCs were derived from the striatum of embryonic day 17 (El 7) 
C57BL/6 mouse embryos. After trypsin digestion and trituration of neural tissue, cells were 
resuspended in NB medium supplemented with B27, 10% horse serum, 500 pM L-glutamine, 
25 pM L-glutamate, 200 units/ml penicillin, and 200 pg/ml streptomycin and seeded at 1x10s 
cells/cm2 into poly-L-lysine-coated wells and incubated under standard conditions to obtain 
mixed primary neuron-glia cultures (PNGs). Cultures were supplied with fresh medium by 
exchange of half of the culture medium every 4 days. To obtain primary neuronal cultures 
(PNs), 24 hr after plating, the medium was changed to serum-free NB medium supplemented 
with B27, 500 pM L-glutamine, 200 units/ml penicillin and 200 pg/streptomycin and treated 
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on day 4 with 10 pM cytosine 1 -P-D-arabinofuranoside for 24 h to inhibit glial growth. 
Primary glial cell cultures (PGs) were grown as described previously (Jeftinija et al., 1996) 
Co-cultures of NSCs with primary cells NSCs were added at 5x103 cells/well either 
directly to 6-day-old cultures of PCs (PNGs or PNs; 105 cells/well) or co-cultured on a 
membranous polyester insert (Costar Trans well; 6.5 mm diameter and 0.4 pm pore size) 
above the primary cells. The co-culture medium consisted of Neurobasal (NB) medium 
supplemented with B27, 500 pM L-glutamine, 200 units/ml penicillin, and 200 pg/ml 
streptomycin, heparin (8pg/ml), bFGF (20 ng/ml) and EGF (20 ng/ml). 
Induction of oxidative stress in vitro Oxidative stress was induced in 7-day-old PCs by 
treatment of PNGs with 0.1 mM 3-NP, PGs with 0.25 mM, and PNs with 0.05mM 3-NP for 
48 hours according to our previously established dose/time-response curves. The use of three 
doses reflected the varying sensitivity of PNs, PNGs, and PGs to 3-NP and all treatments 
resulted in comparable oxidative stress in all three culture types. In the case when NSCs or 
3T3 cells were added to the PCs, 3-NP was added 24 hrs later. After removal of 3-NP, the 
cells were rinsed and analyzed at three time intervals over 72 hrs. 
To account for the possibility that some NSC-secreted factors might have inactivated 
3-NP during the 48-hr treatment of the co-cultures, we removed their medium thereafter, 
treated it with neutralizing antibodies overnight to inactivate the secreted growth factors (see 
below), and added this medium back to fresh cultures of PNGs, PGs, and PNs. The 3-NP-
mediated effects on mitochondrial activity, intracellular ROS levels, and apoptosis could still 
be recorded and occurred with undiminished strength. 
Cell culture paradigms 1) PCs only (no 3-NP), 2) NSCs only (no 3-NP), 3) PCs + 3-NP, 4) 
NSCs + 3-NP, 5) co-culture of NSCs with PCs before the addition of 3-NP, 6) co-culture of 
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NSCs with PCs (no 3-NP) 7) co-culture of 3T3 cells with PCs before the addition of 3-NP 
and 8) co-culture of 3T3 cells with PCs (no-3-NP). Co-cultures of NSCs with PCs occurred 
either with or without separating polyester inserts (see above for specification). 
Inhibition of growth factor signaling A titration was first conducted with different 
concentrations of the neutralizing antibodies and a dose-response curve was generated to 
determine the optimal concentrations to be used. Then, neutralizing antibodies against 
VEGF, CNTF, and BDNF were added to the co-cultures 24 hrs prior to the addition of 3-NP, 
at concentrations of 1, 2 and 0.5 pg/ml respectively. Their presence was maintained also after 
3-NP was removed. 
MTT assay Cell viability assessment during the co-culture studies was made using the 
standard colorimetric 3,[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) 
assay as described previously (Hansen et al., 1989). 
Production of ROS The presence of ROS was evaluated in a 5-(and-6)-chloromethyl-2',7'-
dichlorodihydrofluorescein diacetate (CM-HaDCFDA) fluorescence assay as described 
(Ohba et al., 1994; Shimazawa et al., 2005). 
Detection of apoptosis Apoptotic cells in vitro were detected in a standard nuclear stain 
with the Hoechst dye 33342 and cells with apoptotic (condensed and/or fragmented) nuclei 
were quantified as described (Madhavan et al., 2003). 
Immunocytochemistry Cells were fixed with 4% paraformaldehyde (PFA), washed 3x5 
min. with 0.1 M PBS, and blocked for 2 hr in 5% goat serum in PBS supplemented with 0.2% 
BSA, 0.1% Triton X-100. Incubation with primary antibodies (Abs) diluted in blocking 
solution occurred overnight at 4°C. After washing, the appropriate fluorescent secondary 
antibodies were applied for Vi hr at room temperature (RT). Coverslips mounted in 
Vectashield medium were analyzed using a Zeiss Axioplan 2 microscope and images 
captured with a Zeiss AxioCam digital camera and Axiovision 4 software. The following cell 
markers and factors were detected: nestin (Ab dilution 1:500) and Ki-67 (1:500) for detection 
of NSCs and proliferating cells; class III-P-tubulin (Tujl; 1:300) and microtubule-associated 
protein 2ab (MAP2ab; 1:500) as neuronal markers; glial fibrillary acidic protein (GFAP; 
1:1000) and S-100P (1:1000) as astroglial markers; 2'3 '-cyclic-nucleotide 3'-
phosphodiesterase (CNP; 1:500) as marker for oligodendrocytes; monitored was also 
expression of CNTF (1:250), BDNF (1: 1000), VEGF (1:250), GDNF (1: 500), NT-3 
(1:500), and of the antioxidant SOD2 (1:500). 
Protein quantification by ELISA Medium was collected from the various co-cultures, and 
its content in growth factors determined using an R & D Quantikine ELISA Immunoassay kit 
following the recommendations of the manufacturer (R&D systems, Minneapolis, MN). 
Pure growth factor proteins provided in the kit were used to establish standard curves for 
quantification. 
Western blot analysis Forty-eight hours after 3-NP treatment, PCs were harvested, washed 
with ice-cold Ca2+-free PBS, and resuspended in 2 ml of homogenization buffer (20 mM 
Tris-HCl pH 8.0, 10 mM EGTA, 2 mM EDTA, 2 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, 25 pg/ml aprotinin, and 10 pg/ml leupeptin). Suspensions 
were sonicated and supematants collected as whole cell lysate fractions. Equal amounts of 
protein were then loaded on a 15% SDS-polyacrylamide gel and the size-separated proteins 
transferred to a nitrocellulose membrane by electroblotting. The presence of SOD2 was 
revealed by incubating the membranes with specific antibodies using Amersham's ECL 
chemiluminescence kit. Equal protein loading in blots was confirmed by their re-probing with 
a monoclonal Ab against a-tubulin. 
In vivo studies 
Animals 16-20-week-old male C57BL/6 mice (Harlan, Indianapolis, IN) were housed and 
maintained at Iowa State University and all animal procedures carried out were approved by 
the Iowa State University Committee on Animal care and adhered to NIH guidelines (Public 
Health Service Policy on Humane Care and Use of Laboratory Animals, 2002). The 
experimental groups and the number of animals in each group were as follows: 1) mice 
grafted with vehicle (Hank's Balanced Salt Solution; HBSS) and 3-NP injected (n=22); 2) 
mice grafted with NSCs and 3-NP injected (n=17); 3) mice grafted with 3T3 cells and 3-NP 
injected (n=10); 4) intact mice (n=10); 5) intact mice grafted with NSCs (n=15). Mice from 
1) and 3) were collectively defined as "mock-grafted", since both groups presented similar 
behavior and histology throughout this study. The mice were sacrificed at 3 days or 3 weeks 
post-3-NP treatment. 
Transplantation Grafting occurred unilaterally into the intact right striatum of trained mice 
(see below). Anesthetized mice (0.5 mg of pentobarbital (Nembutal) per g.b.w) received 
NSCs, 3T3 cells (both in 1.5 pi of HBBS, 75,000 cells/pi), or an equal volume of vehicle at 
the following stereotactic coordinates: 2 mm anterior to bregma, 1.5 mm lateral to the 
midline, and 2 mm along the dorso-ventral axis. For more details see Ourednik et al. (2002). 
3-NP treatment One week after surgery, animals were subject to subacute striatal damage 
by 3-NP obtained by modification of the strategy employed by Femagut et al. (2002). 
Briefly, the mice received systemic injections of the neurotoxin twice a day, 12 hrs apart, for 
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six days. The number of injections and the dosing were as follows: 4 x 20 mg/kg b. w. 
injections followed by 8 x 40 mg/kg b.w. injections, resulting in a total dose of 400 mg/kg 
b.w. Behavioral testing of the mice started with the first 3-NP injection. 
Experimental Time-Table 
short-term long-term 
grafting survival survival 
3-NP 
, fTTTTH 
0 1 2 3 4 5 6 7  weeks 
I I I I 
behavioral training behavioral testing 
Behavioral training and tests All mice were trained daily in pole and string tests according 
to (Lalonde et al., 1992; Femagut et al., 2002) for two weeks prior to surgery. The behavioral 
testing started from the first day of the 3-NP administration and continued for 3 weeks after 
cessation of the neurotoxin injections. In addition to the pole and string tests, the following 
set of behavior assessments was used for monitoring of motor deficits: 1) general locomotor 
activity, 2) hind limb dystonia, 3) truncal dystonia, 4) hind limb clasping and 5) postural 
challenge (see Table 1). 
Monitoring of the grafted-NSCs Grafted cells were monitored by direct GFP fluorescence 
or by immuno-detection of GFP. 
Histological analyses Mice were sacrificed either 3 days or 3 weeks after the last 3-NP 
injection. Brains were removed, fixed in 4% PFA in 0.1 M PBS, and processed for routine 
cryostat or polyester wax (Ourednik et al., 2002) sectioning. Serial, coronal, 20-pm-thick 
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sections were collected from both striata between coronal levels 151 and 221 as defined in 
the atlas of the mouse brain and spinal cord by Sidman et al. (1971). 
Immunohistochemistry Rehydrated sections were blocked and immunostained over night at 
4°C with Abs against calbindin (Calb; 1:500), neuronal nuclear antigen (NeuN; 1:300), 
MAP2ab (1:250), GFAP (1:1000), S100p (1:1000), CNP (1:100), nestin (1:250), endothelial 
marker (CD 146; 1:100), BDNF (1:250), CNTF (1:100), VEGF (1:100), 4-hydroxy-2-nonenal 
(HNE; 1:500), EDI (1:500) or SOD2 (1:200). The resulting signals were visualized in a 2-hr-
incubation at RT with secondary Abs (1:500) coupled to the fluorochromes Alexa Fluor 488, 
Alexa Fluor 594, or Alexa 647. 
Quantification and data analysis 
In vitro experiments 
All quantifications of cell cultures were done in a blind fashion, using a Zeiss 
Axioplan 2 microscope and images were captured through a 40x objective using Zeiss 
AxioCam digital camera and Axiovision 4 software. Counts were performed from three 
separate experiments and averaged over 15-20 visual fields. 
In vivo experiments 
Behavioral tests String and pole tests were evaluated by the number of falls per five trials 
(with 30s resting time between individual trials) as recorded every day for each animal and 
then averaged over each animal group during the testing phase. Animal motility and posture 
were monitored daily and each animal received a score of 0 (no effect), 1 (mild effect), or 2 
(severe effect) according to the table adapted from Fernagut et al. (2002) in the five 
behavioral categories mentioned above (see Table 1). 
Histology Morphological analyses were performed on blind-coded slides using an 
inverted Nikon Eclipse microscope, with a Hamamatsu C4742-95 digital camera controlled 
by Prairie Technologies software (Middleton, WI), with image relay to a desk-top computer 
and a motorized X-Y stage. The striatal area was first identified under a 2x objective and 
then sampled under a 40x objective by moving the counting frame systematically through the 
striatal region using the motorized X-Y stage. The Metamorph offline software (Universal 
Imaging, West Chester, PA) was used to automatically count and average cell numbers (only 
for NeuN counts) 
In each section, cells were counted in both hemispheres in animals of all the experimental 
groups. Then, the values of left and right hemisphere were compared and expressed as mean 
percentage values ± S.E.M. of intact controls. All counts and measurements were performed 
on 3-4 adjacent sections using a 40x objective and within coronal level 2 according to 
Fernagut et al. (2002) and the Atlas of mouse brain and spinal cord by Sidman et al. (1971), 
page 25-28. We chose this area since it was there where maximal lesioning was expected 
(Fernagut et al., 2002) and indeed observed in sham-operated controls after 3-NP intoxication 
(common for all groups) 
Cell counts -The expression of CNTF and VEGF in donor NSCs, host astrocytes, and host 
endothelial cells as well as host striatal neurons double-labeled for NeuN and SOD2 were 
determined in all grafted animals and cell numbers were calculated from 3 adjacent coronal 
sections (measured in the dorsolateral area as shown by circles in drawing in Fig. 8). 
Counted were also host striatal neurons expressing NeuN only all over striatum as shown by 
slashed area in drawing in Fig. 8. 
Blood vessel diameters - The blood vessel diameters were measured in the dorsolateral area 
(circles in the drawing in Fig. 8) using the morphometric tools provided by the Axiovision 4 
software. 
All counts were conducted in both the right and left striatum and in all the 
experimental animal groups. 
Statistics All data are expressed as mean ± S.E.M., and statistical significance is 
determined by analyses of variance (ANOVA) with Dunnett's post hoc test for multiple 
comparisons with the control or Bonferoni's multiple comparison tests for multiple 
comparisons between treatment groups. Significance of single comparisons was determined 
in a Student's t test or the Welch-corrected unpaired t test, where appropriate. A minimal 
probability of p<0.05 was considered significant. 
Chemicals 
3-NP was obtained from Sigma (St. Louis, MO); CM-HaDCFDA, MTT, and Hoechst 
33342 were obtained from Molecular Probes (Eugene, OR). All the cell culture supplies were 
purchased from Invitrogen (Carlsbad, CA). Antibodies against the following markers were 
purchased from: nestin, CNP, NeuN, MAP2ab, Calb, CD 146, BDNF, CNTF, GDNF, and 
NT-3 from Chemicon (Temecula, CA); GFAP and S 100|3 from Sigma (St Louis, MO); Tujl 
from Covance (Berkeley, CA); VEGF from Santa Cruz Biotechnology (Santa Cruz, CA); 
HNE from Alpha Diagnostic International (San Antonio, TX); EDI from Serotec 
(Kidlington, Oxford, UK) and SOD2 from Upstate (Lake Placid, NY). Neutralizing 
antibodies against VEGF and CNTF were obtained from R&D Systems (Minneapolis, MN) 
and against BDNF from Chemicon (Temecula,CA). 
RESULTS 
Co-culture with NSCs and the resistance of PCs to oxidative stress 
In an initial titration of 3-NP concentrations on single-cell-type cultures, mixed cultures 
of primary neuronal and glial cells (PNGs) and cultures of primary glia (astrocytes, PGs) 
revealed themselves more resistant to the toxin than primary neuronal cultures (PNs). 
Therefore, in order to elicit the same effects in all three culture types, PNGs were treated with 
0.1 mM 3-NP, PGs with 0.25mM, and PNs with 0.05 mM 3-NP. Treatment of NSCs grown 
alone, consequently, had to be tested with the same three 3-NP concentrations before their co-
culture with PCs. 
While in NSCs cultured alone, only the highest dose of the toxin, 0.25mM, resulted in 
moderate deterioration of cell viability [Fig. 1A-C, dashed lines], all 3-NP concentrations 
induced severe oxidative stress in PCs [Fig. 1D-F], This was reflected in a rapid decay of 
their mitochondrial viability [Fig. ID] and in increasing levels of ROS [Fig. IE], both 
leading to massive apoptosis and cell death [Fig. IF]. 
The survival capacity of the PCs increased substantially when they were co-cultured 
with NSCs prior to 3-NP intoxication [Fig. 1G-L; p<0.05]. This was reflected in increased 
initial resistance of the cells to 3-NP and in their induced recovery, in which PNGs and PGs 
regained almost control values after 72 hours. Notice that co-cultures with PNs [thin lines] 
were consistently and significantly (p<0.02) less resistant than those of PNGs [bold lines] 
and PGs [dashed lines]. This resulted in their noticeably higher initial MTT values [Fig. 
1DGJ], lower levels of free radicals [Fig. 1EHK], and reduced numbers of apoptotic cells 
[Fig. 1FIL], all of which caused a shift of curves in the individual plots. Occasional value 
differences between PNGs and PGs in [G-L] turned out to be insignificant. 
The higher resistance of NSC/PNG and NSC/PG co-cultures allowed them to fully 
recover their viability 72 hrs post-3-NP while co-cultures containing PNs remained affected. 
The main purpose of the cultures including astrocytes as the only PC type was to verify 
possible protective influences originating in neurons. Since, however, the sensitivity of these 
cells and their behavior in co-culture with NSCs were indistinguishable from that of PNGs, 
we focused, in the following, on PNGs and PNs only. Culturing PCs and NSCs in direct 
contact [Fig. 1G-I] or in separate compartments [Fig.lJ-L] had no obvious effects on the 
experimental outcome. This suggested a major involvement of soluble factors in the 
mediation of the neuroprotective effect. 
Effects of NSCs on neuronal cell death in co-culture with PNGs 
Primary astrocytes and neurons were distinguished immunocytochemically by their 
expression of GFAP and MAP2ab and the glial/neuronal index (ratio) calculated over 72 
hours post-3-NP [Fig. 2]. In untreated controls, the total cell number in the cultures 
increased, as did the G/N index [Fig. 2, column A]. Upon 3-NP treatment [Fig. 2, column 
B], a rapid cell death occurred and the concomitantly increasing G/N index revealed that this 
was mostly due to neurons dying during the first 48 hours. Within the next 24 hrs, most of 
the cultured cells had died. This neurotoxic effect of 3-NP on PNGs could be prevented by 
adding of NSCs prior to their intoxication, with or without direct contact between both cell 
types [Fig. 2, columns CD]. This was reflected in G/N indices remaining comparable to the 
untreated controls and in restored survival of the cultures for at least 72 hours. The 
substantially higher vulnerability of neurons to 3-NP compared to that of glia made the 
formers' involvement in NSC-mediated protective effects unlikely and lent support to the 
results represented in Fig. 1. 
3-NP-induced up-regulation of growth factors in vitro 
NSCs without 3-NP exposure and growing alone or in co-culture with PCs produced 
significant amounts of BDNF, CNTF, and VEGF. On the other hand, PCs, especially when 
growing alone, were marked by very low production of these factors. While PNGs still 
expressed measurable amounts of CNTF and VEGF, PNs remained essentially negative in 
the absence of 3-NP. 
NSCs treated with 3-NP when cultured alone up-regulated their expression of CNTF, 
and VEGF as demonstrated by increasing numbers of immuno-positive cells [Fig. 3Aa-c and 
Ba, white columns]. Concentration changes of both factors in the culture medium were 
determined in parallel by ELISA [Fig. 3Bb] No significant changes in BDNF expression 
were found. 
In contrast, there was minimal expression of these factors in PCs alone, even after 
toxin treatment [Fig. 3Bc-f], The same was true when the PCs were co-cultured with NSCs 
in the absence of 3-NP [Fig. 3Cbe, dashed columns]. Upon intoxication, however, a 
massive up-regulation of all three factors could be recorded in the stem cells [Fig. 3Cad, 
white columns] and of CNTF in the primary astrocytes in the NSC/PNG-co-cultures [Fig. 
3Ad-f and Cb, white columns]. Correspondingly, the concentration of total secreted growth 
factors in the co-culture media was enhanced as well [Fig. 3Ccf], Almost no growth factors 
were expressed by neurons [Fig. 3Bef and Ce] and the increase in their secretion measured 
by ELISA in NSC/PN co-cultures [Fig. 3Cf] was the result of NSC secretion only. 
Inhibition of growth factors in NSC/PC co-cultures and its effects on the response of the 
cells to oxidative stress 
To ascertain a functional relationship between the presence of BDNF, CNTF, and 
VEGF and the enhanced resistance of the NSC/PC co-cultures to 3-NP-induced oxidative 
stress, the activity of the growth factors was blocked specifically with neutralizing 
antibodies. The resulting behavior of such co-cultures [Fig. 4, columns B-E] was then 
compared to that of the non-inhibited ones [Fig. 4, column A] and to PCs cultured alone 
[Fig. 4, column F]. In simultaneously processed 3-NP-free controls, the addition of the 
neutralizing antibodies did not produce any toxic effects (not shown). 
While an interference with BDNF activity had no significant effect on the viability of 
NSC/PC co-cultures exposed to 3-NP [Fig. 4, column B], both PNGs and PNs became 
strongly compromised after inhibition of CNTF [Fig. 4, column C] or VEGF [Fig. 4, 
column D] The deterioration of the cultures was obvious from measurements of their 
mitochondrial activities [Fig. 4, row a], levels of ROS [Fig. 4, row b], and numbers of 
apoptotic cells [Fig. 4, row c]. All three parameters deteriorated progressively and cultured 
cells, both PCs and NSCs, were unable to recover from the neurotoxic effects as compared to 
non-inhibited controls [Fig. 4, column A], Interestingly, a substantial number of NSCs 
persisted and survived this growth factor inhibition, indicating that other molecules and 
mechanisms must be contributing as well to their overall better tolerance of oxidative stress 
compared to PCs. A simultaneous neutralization of all three tested growth factors led, not 
surprisingly, to the most severe deterioration of co-culture viability and approached it to that 
of the 3-NP-treated PCs cultured alone [compare columns E and F in Fig. 4], In most 
measurements, interestingly, PNG viability [bold lines] appeared to deteriorate less severely 
(p<0.05) than that of PNs [thin lines]. 
Growth factor production and up-regulation of antioxidant enzymes 
The reduced cell viability and increased ROS production in 3-NP-treated co-cultures 
after growth factor inhibition suggested that these factors may have directly participated in 
the up-regulation of cellular antioxidative defense mechanisms. To explore this possibility, 
we monitored by immunocytochemistry and in Western blots NSC-mediated changes of 
intracellular SOD2 levels. This enzyme represents an important member of the anti-oxidant 
defense system in mammalian cells (Mates and Sanchez-Jimenez, 1999) and has been shown 
to play an important role in quenching of oxidative stress in the striatum (Beal et al., 1995; 
Medina et al., 1996; Andreassen et al., 2001; Kim and Chan, 2002). 
Using SOD2-specific antibodies, we found that the NSCs themselves reacted to 3-NP 
exposure by increased SOD2 expression [Fig. 5A]. This was in harmony with their initially 
found resistance to the toxin (compare Fig. 1A-C and D-F). Interestingly, a similar up-
regulation of this enzyme was also induced in PNGs and PNs co-cultured with NSCs [Fig. 
5Bab and Cab]. On the other hand, when growing alone, untreated and 3-NP-treated PCs did 
not show any change in SOD2 expression [Fig. 5Bb and Cb]. 
Since SOD2 is known to be inducible by VEGF (Abid et al., 2001; Abid et al., 2004) 
and in order to determine the latter's direct involvement in the expression changes of this 
enzyme, we decided to block the growth factor in a set of co-cultures prior to SOD2 
detection. Indeed, this promptly abolished the up-regulation of SOD2 production in the 
cultured cells [Fig. 5Bc and Cc] and corroborated the VEGF-inhibition results depicted in 
[Fig. 4, column D], which had proven this growth factor to be directly involved in the 
enhanced survival of NSC/PC-co-cultures under oxidative stress. These data strongly 
supported the above suggestion of a direct relationship between increased VEGF signaling 
and up-regulation of SOD2 levels in 3-NP-exposed co-cultures. 
Behavioral changes in NSC-grafted and non-grafted mice after 3-NP intoxication 
Systemic exposure of mice to 3-NP, following the schedule modified from the work 
of Fernagut et al. (2002), evoked temporal behavioral changes such as akinesia, hind limb 
dystonia, kyphosis, and postural impairment. The expected spontaneous behavioral recovery 
occurred usually within one month. We asked, whether NSCs grafted one week prior to 3-NP 
intoxication could prevent or reduce the striatal damage and behavioral symptoms, or would 
accelerate the recovery from the latter. Data from these animals were compared with results 
obtained from vehicle- or 3T3-cell-grafted controls (together forming the mock-grafted 
group) and from intact mice [Fig. 6], 
In all 3-NP treated mice (both grafted and non-grafted), no significant motor or 
behavioral signs appeared until the toxin reached a dose of 40 mg/kg b.w. (at the third to 
fourth day of 3-NP injection). After the first 2-4 injections, the animals became hyperactive 
and their scores in pole [Fig. 6A] and string [Fig. 6B] tests began to worsen. This was 
accompanied by progressive akinesia, inactivity, and motor deficits such as reduced 
exploratory behavior, hind limb clasping, and hind limb and truncal dystonia [Fig. 6C], At 
the last day of 3-NP administration, four mock-grafted animals died and another one was 
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doing very poorly (score 9) and died during the next day. One out of the seventeen NSC-
grafted mice was also strongly affected (score 9) and died within two hours after the last 3-
NP injection. (This animal was perfused immediately for histotopathology. No donor cells 
could be found in its brain.) 
The behavioral tests demonstrated significant differences between the mock-grafted, 
3-NP lesioned controls [dashed lines with filled and empty triangles], the intact controls 
[solid lines with empty circles], and the NSC-grafted, 3-NP-treated [solid lines with filled 
circles] animals. The contrast was reflected mostly in the following parameters of motor 
deficits: peak values (the higher the value, the worse the symptoms), length of the recovery 
period, and degree of recovery. While animals without NSC implants [dashed lines] were 
significantly more vulnerable to 3-NP (much higher scores on deficit scale, longer and 
incomplete recovery), the NSC-grafted mice resisted the intoxication much more effectively 
in all three parameters. 
Changes of striatal cytoarchitecture in NSC-grafted and control mice after systemic 3-
NP intoxication 
Mock-grafted controls 
Three days after 3-NP treatment, characteristic pale "lesion spots" (with diameter 
range of about 350-450 pm) were seen in hematoxylin- and anti-Calb-stained dorso-lateral 
striata in mock-grafted control animals (an example of vehicle-grafted mice is shown in [Fig. 
7Aa-d]). These weakly stained areas of degeneration were surrounded GFAP positive cells 
and presented ongoing neural cell loss with many pycnotic (dark shrunken nuclei indicating 
early stages of apoptosis; [Fig. 7Bc], Harmon and Allan, 1988) and necrotic (swollen and 
pale cytoplasm; open arrow and insert in [Fig. 7Bc]) cells and significantly dilated [Figs. 
7Ba and 8Aab, black columns], occasionally ruptured blood vessels [hematoma and red 
blood cells in Fig. 7Bb], In order to assess the 3-NP-induced damage of striatal neurons in 
these controls, we quantified the change in NeuN-positive cell numbers and found them to be 
reduced by about 35% in both hemispheres [Fig. 8Bab, black columns]. The 
immunodetection of increased levels of HNE - a product of lipid peroxidation accumulating 
in cell membranes - revealed the presence of oxidative stress in these damaged areas (see 
Fig. lOAb). 
At three weeks post-3-NP, despite the behavioral amelioration of the mock-grafted 
control mice [Fig. 6], the bilateral reduction in their striatal neurons still persisted [Fig. 
8Bab, white columns]. On the other hand, no pale "lesion spots" remained detectable and 
only some residual pycnotic cells. Dilation of blood vessels, although still noticeable, was 
significantly reduced in both hemispheres [Fig. 8Aab, white columns], as was the 
production of HNE (not shown). 
NSC-grafted animals 
Monitoring of donor cells While in intact striata, NSCs did not migrate and remained close 
to the injection site during the entire experimental 3-week-period, 3-NP exposure stimulated 
their migratory activity. Three days after the last 3-NP injection (i.e., 2 weeks and 3 days 
after grafting; see "3-NP treatment" in M & M), GFP-positive cells were still mainly found 
unilaterally in the area of their deposit [see black dots in coronal slice drawings in Fig. 7A], 
Three weeks post-3-NP, on the other hand, grafted cells had dispersed within the ipsilateral 
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striatum. Signaling from "tissue in distress" (Aboody et al., 2000; Ourednik et al., 2002) also 
induced weak contralateral migration of the grafted NSCs as well (see bottom schema in Fig. 
7A). However, their delayed arrival and relatively low numbers prevented the NSCs from 
interfering with contralateral tissue damage, which resembled that of mock-grafted controls. 
Only rarely were donor cells found in other brain regions. Interestingly, many of these NSCs 
were situated close to blood vessels. 
During the entire experimental time period, about 75% of the implanted NSCs 
remained undifferentiated and nestin-positive [Fig. 7Cfg]; the others matured mostly into 
GFAP-positive astrocytes [Fig. 7Chi] and a minority into cell expressing NeuN [Fig. 7Bd] or 
CNP [Fig. 7Be]. No donor NSC progeny was found to express the endothelial marker 
CD146. 
Response of host tissue When compared to 3-NP-treated controls [Fig. 7Aa-d], in animals 
grafted with NSCs, no initial (three days after toxin exposure) appearance of cell-depleted 
"spots" or areas of vascular damage were observed in the ipsilateral hemisphere [Fig. 7Aef 
and 8Ba, black columns]. Also, as in the intact controls, no elevated HNE positivity was 
found (see also Fig. 10 below). In contrast, the temporal emergence of "lesion spots" in the 
contralateral (non-grafted) hemisphere [Fig. 7Agh] appeared similar to that in the animals 
not receiving NSC-grafts prior to intoxication [Fig. 7Acd], Correspondingly, the numbers of 
striatal neurons ipsilateral to the NSC deposit remained at almost intact values [Fig. 8Ba, 
black columns] while in the non-grafted hemisphere they became reduced similarly to the 
neurons in mock-grafted controls [Fig. 8Bb, black columns]. In NSC-grafted control mice 
not treated with 3-NP, neither changes in neuronal cell numbers nor vascular dilation were 
detected. 
Three weeks post-3-NP, due to spontaneous tissue re-organization, no striatal "lesion 
spots" were found in any of the experimental animals. In contrast to the mock-grafted group, 
however, in the NSC-grafted animals, NeuN-positive cells were preserved in the grafted 
hemisphere [Fig. 8Ba, white columns] and only contralateral^, neuronal numbers were 
similarly decreased as in the controls [Fig. 8Bb, white columns] 
Molecular and cellular processes accompanying NSC-mediated neuroprotection in vivo 
Production of growth factors To investigate possible up-regulation of growth factors related 
to the neuroprotective phenomena described above, and based on our in vitro results, we 
immunostained the striatal sections for the presence of BDNF, CNTF, and VEGF. 
At three days post-3-NP treatment, elevated expression of growth factors was 
observed in the grafted hemispheres and, interestingly, originated from both donor and host 
cells. Large subpopulations of undifferentiated GFP-positive donor cells expressed CNTF 
(-80%) and VEGF (-60%) [Fig.9Aa-c, Ag-i and plot Ba] while only a small fraction of their 
differentiated progeny, namely astrocytes, produced these growth factors as well. On the 
other hand, many of the host astrocytes (-75%; expressing S 100(3 but not GFP) stained 
positively for CNTF [Fig. 9Ad-f and plot Bb] and about 60% of the endothelial cells 
produced VEGF [Fig. 9Ajk and plot Be]. Besides their GFP-negativity, the host origin of 
these cells was supported by their mature morphology (post-grafting time was too short for 
the donor NSCs to fully differentiate and most of the donor NSCs remained undifferentiated, 
as mentioned above). Only weak staining of growth factors was detected in the brains of 
intact and mock-grafted, 3-NP-treated animals [Fig. 9, plots Bbc]. 
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By 3 weeks after 3-NP exposure, donor and host expression of CNTF and VEGF in 
NSC-grafted mice had diminished and was again comparable to that of intact animals (not 
shown). BDNF remained weakly expressed in all the experimental animals at both time 
intervals. 
Up-regulation of SOD2 and prevention of oxidative stress Together with our findings in 
vitro, the above data describing enhanced growth factor production and decreased oxidative 
stress effects in the NSC-transplanted striata suggested a possible up-regulation of anti-
oxidative enzymes by these factors. We explored this possibility by monitoring the levels of 
SOD2 in the areas of increased growth factor expression. 
In mock-grafted animals, SOD2 production was insignificant at 3 days after 3-NP 
treatment and the strong HNE-specific staining revealed persistence of oxidative striatal 
damage [Fig. lOAb and Bb]. In NSC-grafted, 3-NP-treated animals, on the other hand, we 
observed a strong expression of SOD2 in graft and host cells, the latter including neurons 
[Fig. 10 Ac and C]. The resulting reduction in oxidative stress was reflected in down-
regulation of the NHE signal, which now was of much lower intensity and comparable to that 
in intact animals [compare Fig. 10 Ba and Be] Since cytokines secreted by activated 
microglia were shown to induce SOD2 (Wong and Goeddel, 1988) as well and could have 
blurred the role of the donor NSCs in the grafted animals, we also stained sections from all 
animal groups for the presence of the microglial marker EDI. We found, however, no 
evidence indicating a significant participation of this cell type in the neuroprotective 
networks. 
The up-regulation of SOD2 disappeared by 3 weeks post-3-NP and regained the 
intensity found in intact animals. 
All the collected data in this study support our hypothesis that cellular networking of 
NSCs, astrocytes, and - in vivo - endothelial cells is capable of controlling homeostasis in a 
niche challenged by oxidative stress. This control appears to be based on a network-induced, 
elevated production of growth factor in the three participating cell types, which ultimately 
results in the activation of effective anti-oxidant defense mechanisms in neurons. 
DISCUSSION 
The mode of action of growth factors in the intricate dialogue between stem cells and 
their microenvironment is complex and does involve many parallel signaling pathways. 
Depending on the environmental context, one or the other of them may become the dominant 
one and determine the final cell behavior. How this is controlled and which environmental 
input selects which pathway is, however, still poorly understood. 
The present study provides evidence that, under oxidative stress, growth factors 
produced by NSCs can directly regulate the activation of anti-oxidant defense mechanisms. 
In a newly established network of growth-factor-producing NSCs, astrocytes, and even non-
neural cells such as the endothelial cells, this collaborative effort to re-establish homeostasis 
ultimately leads to up-regulation of antioxidants like the superoxide detoxifier SOD2, and 
provides a molecular basis for cellular protection and rescue. 
Recently, it has been demonstrated that exogenous stem cells possess an inherent 
ability to create host micro-environments that favor recovery or preservation of damaged or 
imperiled cells (Ourednik et al., 2002; Park et al., 2002; Teng et al., 2002; Lu et al., 2003; 
Ryu et al., 2004; Yan et al., 2004; Pluchino et al., 2005). It soon became evident that this 
return to homeostasis is many times accompanied by the intrinsic production and secretion of 
a variety of donor NSC-derived growth factors, including GDNF, NT-3, BDNF, and NGF 
(Ourednik et al., 2002; Teng et al., 2002; Lu et al., 2003; Maurer et al., 2003; Imitola et al., 
2004; Ryu et al., 2004; Brusselmans et al., 2005). As demonstrated in this study, the baseline 
expression of growth factors in NSCs is already substantially higher than in mature neural 
cell types and also increases more vigorously upon arrival of oxidative stress. This "sternness 
feature" would appear crucial for the usefulness of NSCs in neurotransplantation since they 
need to resist the hostile environment of the diseased nervous system in order to exert their 
beneficial influence. The latter, as documented by the here adduced in vitro and in vivo data, 
becomes particularly effective when exogenous NSCs are present already before an insult 
and can prevent cell damage upon its arrival. Thus, in the grafted, 3-NP-treated mice, 
ipsilateral to the site of a NSC deposit, host striatal neurons were protected from oxidative 
stress and their numbers did not decline. 
We observed that NSCs, in contrast to PCs, produced significant amounts of BDNF, 
CNTF, and VEGF and could induce astrocytic production of CNTF in co-cultures with PNGs 
(mixed primary neurons and glial cells) and PGs (primary astrocytes) exposed to 3-NP. This 
resulted in higher resistance of both PNGs and PGs to the toxin when compared to PNs. The 
fact that NSC/PG co-cultures appeared to be slightly less protected than cultures of NSCs 
with PNGs (even though the differences proved statistically insignificant) may have reflected 
the greater struggle of the NSCs themselves in presence of the elevated 3-NP concentration 
required in the co-cultures with PGs. Similarly, in vivo, an intimate interaction between 
grafted NSCs and host astrocytes was associated, after a subsequent exposure of the 
recipients to oxidative stress, with up-regulation of astrocytic CNTF and with sparing of 
neurons and neural tissue integrity. As described recently, astrocytes possess a variety of 
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homeostasis-regulating properties and represent important and influential components in the 
stem cell niche (Svendsen, 2002; Doetsch, 2003; Horner and Palmer, 2003). Here, we may 
assign to them a new capability, namely, responsiveness to NSC signaling in presence of 
injury, reflected in their enhanced secretion of neuroprotective factors. 
Intriguingly, astrocytes were not the only host cell type found to interact with grafted 
NSCs in the presence of 3-NP. We observed that, under oxidative stress, an interaction 
between grafted NSCs and endothelial cells can stimulate the latter to increase their VEGF 
synthesis. Several recent reports suggest a role of this factor in increased neurogenesis 
accompanying reciprocal communication between endothelial cells and the 
microenvironment of the neural stem cell niche during development (Palmer et al., 2000; Cao 
et al., 2004; Schanzer et al., 2004; Shen et al., 2004; Wurmser et al., 2004). It also appears 
that, e.g., in adult brain plasticity, endothelial cells do not only participate in angiogenesis but 
also have a neurotrophic and neurogenic impact on neural cells, including stem cells (Jin et 
al., 2002; Cao et al., 2004; Rosenstein and Krum, 2004; Schanzer et al., 2004; Storkebaum et 
al., 2004; Wurmser et al., 2004). Since regeneration in the CNS often induces cellular and 
molecular processes that, to a certain degree, "revisit" events guiding neural development 
and plasticity, the NSC-mediated endothelial up-regulation of VEGF observed in this study 
could have been such a "review" of neuro-morphological events, now contributing to the 
neuroprotective/regenerative processes. 
An important quality of VEGF and CNTF is their ability to promote cellular 
resistance against oxidative stress. CNTF can stimulate the JAK/STAT and MAPK pathways 
(Bonni et al., 1997; Kuroda et al., 2001; Ozog et al., 2004) and VEGF can up-regulate SOD2 
(Abid et al., 2001; Abid et al., 2004), both of which may in part, be responsible for their 
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antioxidant functions. Since NSCs, neurons, and glial cells have all been shown to express 
CNTF and VEGF receptors and the latter receptor type is also found on endothelial cells 
(Sondell et al., 2000; Jin et al., 2002; Emsley and Hagg, 2003; Maurer et al., 2003; 
Rosenstein et al., 2003; Alberch et al., 2004; Storkebaum et al., 2004), these factors were 
likely to contribute to the observed NSC-mediated prevention of 3-NP-induced striatal 
damage. 
Since the improved NSC-mediated resistance of mature neural cells to oxidative 
stress was associated, both in vitro and in vivo, with enhanced cellular production and 
secretion of growth factors, it suggested their direct control of the cellular antioxidant 
response. It appears that VEGF can be regulated by cellular redox processes and oxidative 
stress (Maulik, 2002; Schafer et al., 2003; Eyries et al., 2004) and can control the production 
of SOD2 in non-neural (endothelial and pulmonary) cells (Abid et al., 2001; Abid et al., 
2004; BelAiba et al., 2004). Thus, growth-factor-mediated changes in SOD2 expression 
might be, at least in part, directly responsible for the increased cellular resistance of NSCs 
and other neural cells to 3-NP-induced oxidative stress described in this report. 
Indeed, we found an involvement of SOD2 in the cellular response to 3-NP-exposure 
in cultured NSCs and in their co-cultures with PNGs and PNs, as well as in the vicinity of 
grafted cells in 3-NP-treated mouse striata. Here, not only did the grafted NSCs strongly 
express SOD2, but their presence was associated with an induction of the antioxidant in the 
resident cells, including neurons, and in efficient maintenance of local tissue homeostasis 
apparent by the reduced striatal HNE staining. Corroborating this finding, a critical 
involvement of superoxide in 3-NP-induced excitotoxic damage in the brain and its increased 
vulnerability in SOD2-knockout mice has recently been suggested (Andreassen et al., 2001; 
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Kim and Chan, 2002). Since we did not detect any significant presence of a local 
inflammatory response recruiting activated microglia, it is unlikely that SOD2 might have 
been up-regulated by cytokines. 
We could test our hypothesis of growth-factor-mediated control of stress-related 
redox processes by blocking of the action of VEGF with neutralizing antibodies in vitro. 
Intriguingly, the resulting elimination of cell survival capability (a similar effect was also 
observed after blocking the action of BDNF and CNTF) was accompanied by a marked loss 
of SOD2 expression and demonstrated a direct relationship between VEGF signaling and up-
regulation of this superoxide detoxifier. Together with CNTF, the VEGF produced by NSCs 
and endothelial cells in vivo was therefore likely to have contributed efficiently to the 
protection of host striatal neurons against oxidative stress and their subsequent survival. 
In conclusion, this study provides evidence that direct activation and control of 
antioxidant defense mechanisms through growth factor signaling appears to accompany 
NSC-mediated neuroprotection. NSCs can thereby act as cellular "probes" and initiate an 
appropriate network of growth factor-producing cells, including themselves and resident 
elements like astrocytes and even the non-neural endothelia. A deeper understanding of this 
novel "recruiting" characteristic of NSCs might add another important element to the 
kaleidoscope of their beneficial features, making these cells a potentially powerful tool for 
preventive treatment of neuropathologies. 
ACKNOWLEDGEMENTS: We thank Nada Pavlovic and Heidi Gabel for technical 
assistance. The work was supported by ISU grants to VO and JO. 
102 
REFERENCES 
Abid MR, Tsai JC, Spokes KC, Deshpande SS, Irani K, Aird WC (2001) Vascular 
endothelial growth factor induces manganese-superoxide dismutase expression in 
endothelial cells by a Racl-regulated NADPH oxidase-dependent mechanism. 
FASEB J 15:2548-2550. 
Abid MR, Schoots IG, Spokes KC, Wu SQ, Mawhinney C, Aird WC (2004) Vascular 
endothelial growth factor-mediated induction of manganese superoxide dismutase 
occurs through redox-dependent regulation of forkhead and IkappaB/NF-kappaB. J 
Biol Chem 279:44030-44038. 
Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, 
Ourednik V, Black PM, Breakefield XO, Snyder EY (2000) Neural stem cells display 
extensive tropism for pathology in adult brain: evidence from intracranial gliomas. 
Proc Natl Acad Sci USA 97:12846-12851. 
Alberch J, Perez-Navarro E, Canals JM (2004) Neurotrophic factors in Huntington's disease. 
Prog Brain Res 146:195-229. 
Alvarez-Buylla A, Lim DA (2004) For the long run: maintaining germinal niches in the adult 
brain. Neuron 41:683-686. 
Andreassen OA, Ferrante RJ, Dedeoglu A, Albers DW, Klivenyi P, Carlson EJ, Epstein CJ, 
Beal MF (2001) Mice with a partial deficiency of manganese superoxide dismutase 
show increased vulnerability to the mitochondrial toxins malonate, 3-nitropropionic 
acid, and MPTP. Exp Neurol 167:189-195. 
Beal MF, Ferrante RJ, Henshaw R, Matthews RT, Chan PH, Kowall NW, Epstein CJ, Schulz 
JB (1995) 3-Nitropropionic acid neurotoxicity is attenuated in copper/zinc superoxide 
dismutase transgenic mice. J Neurochem 65:919-922. 
Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava 
R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of 
striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. 
J Neurosci 13:4181-4192. 
BelAiba RS, Djordjevic T, Bonello S, Flugel D, Hess J, Kietzmann T, Gorlach A (2004) 
Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in 
pulmonary artery smooth muscle cells. Biol Chem 385:249-257. 
Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, Rozovsky I, Stahl N, Yancopoulos 
GD, Greenberg ME (1997) Regulation of gliogenesis in the central nervous system by 
the JAK-STAT signaling pathway. Science 278:477-483. 
Brusselmans K, Bono F, Collen D, Herbert JM, Carmeliet P, Dewerchin M (2005) A novel 
role for vascular endothelial growth factor as an autocrine survival factor for 
embryonic stem cells during hypoxia. J Biol Chem 280:3493-3499. 
Cao L, Jiao X, Zuzga DS, Liu Y, Fong DM, Young D, During MJ (2004) VEGF links 
hippocampal activity with neurogenesis, learning and memory. NatGenet 36:827-835. 
Doetsch F (2003) A niche for adult neural stem cells. Curr Opin Genet Dev 13:543-550. 
Emsley JG, Hagg T (2003) Endogenous and exogenous ciliary neurotrophic factor enhances 
forebrain neurogenesis in adult mice. ExpNeurol 183:298-310. 
Eyries M, Collins T, Khachigian LM (2004) Modulation of growth factor gene expression in 
vascular cells by oxidative stress. Endothelium 11:133-139. 
Fernagut PO, Diguet E, Stefanova N, Biran M, Wenning GK, Canioni P, Bioulac B, Tison F 
(2002) Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor 
disorder in adult C57B1/6 mice: behavioural and histopathological characterisation. 
Neuroscience 114:1005-1017. 
Gall CM, Isackson PJ (1989) Limbic seizures increase neuronal production of messenger 
RNA for nerve growth factor. Science 245:758-761. 
Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a 
precise and rapid dye method for measuring cell growth/cell kill. JImmunolMethods 
119:203-210. 
Harmon BV, Allan DJ (1988) X-ray-induced cell death by apoptosis in the immature rat 
cerebellum. Scanning Microsc 2:561-568. 
Hicks RR, Martin VB, Zhang L, Seroogy KB (1999) Mild experimental brain injury 
differentially alters the expression of neurotrophin and neurotrophin receptor mRNAs 
in the hippocampus. Exp Neurol 160:469-478. 
Homer PJ, Palmer TD (2003) New roles for astrocytes: the nightlife of an 'astrocyte'. La vida 
local Trends Neurosci 26:597-603. 
Imitola J, Park KI, Teng YD, Nisim S, Lachyankar M, Ourednik J, Mueller FJ, Yiou R, Atala 
A, Sidman RL, Tuszynski M, Khoury SJ, Snyder EY (2004) Stem cells: cross-talk 
and developmental programs. Philos Trans R Soc Lond B Biol Sci 359:823-837. 
Jeftinija SD, Jeftinija KV, Stefanovic, G (1996) Neuroligand-evoked calcium-dependent 
release of excitatory amino acids from cultured astrocytes. J Neurochem 66:676-84. 
Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA (2002) Vascular endothelial growth 
factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 
99:11946-11950. 
Kim GW, Chan PH (2002) Involvement of superoxide in excitotoxicity and DNA 
fragmentation in striatal vulnerability in mice after treatment with the mitochondrial 
toxin, 3-nitropropionic acid. J Cereb Blood Flow Metab 22:798-809. 
Kuroda H, Sugimoto T, Horii Y, Sawada T (2001) Signaling pathway of ciliary neurotrophic 
factor in neuroblastoma cell lines. Med Pediatr Oncol 36:118-121. 
Lalonde R, Botez MI, Joyal CC, Caumartin M (1992) Motor abnormalities in lurcher mutant 
mice. Physiol Behav 51:523-525. 
Lu P, Jones LL, Snyder EY, Tuszynski MH (2003) Neural stem cells constitutively secrete 
neurotrophic factors and promote extensive host axonal growth after spinal cord 
injury. Exp Neurol 181:115-129. 
Madhavan L, Freed WJ, Anantharam V, Kanthasamy AG (2003) 5-hydroxytryptamine 1A 
receptor activation protects against N-methyl-D-aspartate-induced apoptotic cell 
death in striatal and mesencephalic cultures. J Pharmacol Exp Ther 304:913-923. 
Mates JM, Sanchez-Jimenez F (1999) Antioxidant enzymes and their implications in 
pathophysiologic processes. Front Biosci 4:D339. 
Maulik N (2002) Redox signaling of angiogenesis. Antioxid Redox Signal 4:805. 
Maurer MH, Tripps WK, Feldmann RE, Jr., Kuschinsky W (2003) Expression of vascular 
endothelial growth factor and its receptors in rat neural stem cells. Neurosci Lett 
344:165-168. 
106 
Medina L, Figueredo-Cardenas G, Reiner A (1996) Differential abundance of superoxide 
dismutase in intemeurons versus projection neurons and in matrix versus striosome 
neurons in monkey striatum. Brain Res 708:59-70. 
Ohba M, Shibanuma M, Kuroki T, Nose K (1994) Production of hydrogen peroxide by 
transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse 
osteoblastic cells. J Cell Biol 126:1079-1088. 
Ourednik J, Ourednik V, Lynch WP, Schachner M, Snyder EY (2002) Neural stem cells 
display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 
20:1103-1110. 
Ourednik V, Ourednik J (2005) Graft/Host relationships in the developing and regenerating 
CNS of mammals. Ann N Y Acad Sci 1049:172-184. 
Ourednik V, Ourednik J, Flax JD, Zawada WM, Hutt C, Yang C, Park KI, Kim SU, Sidman 
RL, Freed CR, Snyder EY (2001) Segregation of human neural stem cells in the 
developing primate forebrain. Science 293:1820-1824. 
Ozog MA, Bemier SM, Bates DC, Chatterjee B, Lo CW, Naus CC (2004) The complex of 
ciliary neurotrophic factor-ciliary neurotrophic factor receptor alpha up-regulates 
connexin43 and intercellular coupling in astrocytes via the Janus tyrosine 
kinase/signal transducer and activator of transcription pathway. Mol Biol Cell 
15:4761-4774. 
Palmer TD, Willhoite AR, Gage FH (2000) Vascular niche for adult hippocampal 
neurogenesis. J Comp Neurol 425:479-494. 
107 
Park KI, Teng YD, Snyder EY (2002) The injured brain interacts reciprocally with neural 
stem cells supported by scaffolds to reconstitute lost tissue. NatBiotechnol 20:1111-
1117. 
Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini 
A, Bergami A, Furlan R, Comi G, Constantin G, Martino G (2005) Neurosphere-
derived multipotent precursors promote neuroprotection by an immunomodulatory 
mechanism. Nature 436:266-271. 
Rappa G, Lorico A, Hildinger M, Fodstad O, Baum C (2001) Novel bicistronic retroviral 
vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance 
protein 1 (MRP1) protects cells from MRPl-effluxed drugs and alkylating agents. 
Hum Gene Ther 12:1785-1796. 
Rosenstein JM, Krum JM (2004) New roles for VEGF in nervous tissue—beyond blood 
vessels. Exp Neurol 187:246-253. 
Rosenstein JM, Mani N, Khaibullina A, Krum JM (2003) Neurotrophic effects of vascular 
endothelial growth factor on organotypic cortical expiants and primary cortical 
neurons. J Neurosci 23:11036-11044. 
Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, Choi HB, Lee MC, McLamon JG, Kim SU 
(2004) Proactive transplantation of human neural stem cells prevents degeneration of 
striatal neurons in a rat model of Huntington disease. Neurobiol Dis 16:68-77. 
Schafer G, Cramer T, Suske G, Kemmner W, Wiedenmann B, Hocker M (2003) Oxidative 
stress regulates vascular endothelial growth factor-A gene transcription through Spl-
and Sp3-dependent activation of two proximal GC-rich promoter elements. J Biol 
Chem 278:8190-8198. 
108 
Schanzer A, Wachs FP, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H, Winkler J, Aigner L, 
Plate KH, Kuhn HG (2004) Direct stimulation of adult neural stem cells in vitro and 
neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 14:237-248. 
Sheen VL, Arnold MW, Wang Y, Macklis JD (1999) Neural precursor differentiation 
following transplantation into neocortex is dependent on intrinsic developmental state 
and receptor competence. Exp Neurol 158:47-62. 
Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, Abramova N, Vincent P, Pumiglia K, Temple 
S (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural 
stem cells. Science 304:1338-1340. 
Shimazawa M, Yamashima T, Agarwal N, Hara H (2005) Neuroprotective effects of 
minocycline against in vitro and in vivo retinal ganglion cell damage. Brain Res 
1053:185-194. 
Sidman RL, Angevine JB Jr and Taber-Pierce E (1971) Atlas of the mouse brain and spinal 
cord. Harvard university press, Cambridge, MA 
Sondell M, Sundler F, Kanje M (2000) Vascular endothelial growth factor is a neurotrophic 
factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci 
12:4243-4254. 
Storkebaum E, Lambrechts D, Carmeliet P (2004) VEGF: once regarded as a specific 
angiogenic factor, now implicated in neuroprotection. Bioessays 26:943-954. 
Svendsen CN (2002) The amazing astrocyte. Nature 417:29-32 
Teng YD, Lavik EB, Qu X, Park KI, Ourednik J, Zurakowski D, Langer R, Snyder EY 
(2002) Functional recovery following traumatic spinal cord injury mediated by a 
109 
unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci USA 
99:3024-3029. 
Wong, G. H. and D. V. Goeddel (1988). Induction of manganous superoxide dismutase by 
tumor necrosis factor: possible protective mechanism. Science 242:941-944. 
Wurmser AE, Palmer TD, Gage FH (2004) Neuroscience. Cellular interactions in the stem 
cell niche. Science 304:1253-1255. 
Yan J, Welsh AM, Bora SH, Snyder EY, Koliatsos VE (2004) Differentiation and 
tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J Comp 
Neurol 480:101-114. 
Figure 1 
Co-culture with NSCs increases the resistance of PCs to oxidative stress Cell cultures 
were exposed to 3-NP and the effects on mitochondrial viability, levels of ROS, and 
apoptotic cell death measured. Treated were either NSCs alone [A-C], PCs alone [D-F], or 
their co-cultures in absence [G-I] or presence [J-L] of a separating, porous insert. Three 
types of PCs were evaluated: primary neurons and glial cells [PNGs; bold lines in D-L], 
primary glial cells [astrocytes, PGs; dashed lines in D-L] and primary neurons [PNs; thin 
lines in D-L] For reasons of different sensitivity to the toxin (see M&M), each type of PCs 
was exposed to its specific concentration of 3-NP and NSCs grown alone to all three 
concentration [A-C; see M&M]. Measurement of all parameters started 24 hrs after 3-NP 
removal. While MTT values and changes in ROS levels are expressed in % of untreated 
controls, apoptosis is expressed as percentage of apoptotic cells in culture. NSCs alone [A-C] 
were significantly less sensitive to the toxin than PCs alone [D-F]. The vulnerability of the 
PCs decreased, however, substantially when they were co-cultured with NSCs prior to 3-NP 
intoxication [G-L; p<0.05]. This was reflected in increased initial resistance of the cells to 3-
NP and in their induced recovery, in which PNGs and PGs regained almost control values 
after 72 hours. Separating NSCs form PCs by inserts had no significant effects. 
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Figure 2 
3-NP-induced changes in cell numbers and glial/neuronal ratios (G/N indices) of PNGs 
are modulated by co-culture with NSCs Cell numbers [upper graphs] and G/N indices 
[bottom graphs] in untreated [A] and 3-NP treated [B)] PNGs alone were compared with 
those of PNGs co-cultured with NSCs in absence [C] or presence [D] of a separating porous 
insert. Cells were monitored during the first three 24-hour-intervals post-intoxication and 
their numbers normalized to a hypothetical standard culture of 100 cells. NSCs prevented 3-
NP-induced cell death in PNGs as judged from the difference in cell numbers between co-
cultures [C and D] and the 3-NP-treated PNG controls [B]. The latter died rapidly, with their 
G/N index rising explosively at 48 hrs, which suggested that 3-NP affected primary neurons 
more severely than glia and that the presence of NSCs provided their protection. At 72 hours, 
virtually all cells in the PNG-only controls were dead and the remainder made measurement 
of a meaningful G/N index impossible [hence n/a]. 
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Figure 3 
Expression of growth factors by NSCs and PCs cultivated alone or in co-cultures 
Single-type cell cultures and co-cultures were grown with or without exposure to 3-NP and 
the percentage of cells expressing BDNF, CNTF, and VEGF quantified 
immunocytochemically two days after 3-NP treatment (or after two days in vitro for the 
controls). The content of growth factors in the culture media was quantified in parallel in an 
ELISA assay. [A] microphotographs with examples of the expression of all three growth 
factors in NSCs [a-c] and of CNTF in primary astrocytes in PNGs/NSCs co-cultures 
responding to 3-NP-intoxication [d-f]. When cultured alone, significantly more NSCs 
expressed CNTF and VEGF after 3-NP treatment than in untreated controls [Bab]. In 
contrast, PCs alone produced minimal amounts of growth factors, irrespective of toxin 
exposure [Bc-f]. When NSCs co-cultured with either PNGs or PNs were treated with 3-NP, 
their numbers now expressing all three factors increased substantially [Cad], while only one 
of the factors, CNTF, was up-regulated in PCs and this only in primary astrocytes [Ad-f and 
Cb], Increasing numbers of factor-expressing cells were always reflected in higher 
concentrations of the secreted proteins in the culture media [Bb and Ccfj. *p<0.05, 
**p<0.01, ***p<0.001 when compared to untreated controls. Bars: 20 pm [Aa-c], 40 pm 
[Ad-f]. 
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Figure 5 
Growth factor-dependent up-regulation of SOD2 in NSC/PC co-cultures under 
oxidative stress Changes in SOD2 expression and its regulation by secreted growth 
factors 48 hours post-3-NP were monitored by immunocytochemistry [Ba and Ca] and in 
Western blots [A, Bbc, and Cbc]. In the first case, an SOD2-specific antibody revealed an 
up-regulation of this enzyme in both PNGs [Ba; red combined with blue nuclear DAPI 
stain] and PNs [Ca; red, merged image with double-stain against NeuN - green]. Western 
blots revealed that NSCs cultured alone up-regulated SOD2 in response to 3-NP [A]. Similar 
activation of the enzyme was revealed in primary cultures [Bb and Cb] but only when NSCs 
were present before 3-NP treatment while untreated co-cultures and 3-NP-treated PCs 
cultivated alone always showed significantly lower SOD2 expression. The up-regulation of 
SOD2 was effectively inhibited when VEGF activity was blocked with neutralizing 
antibodies [Be and Ce], Equal protein loading in Western blots was verified by detection of 
a-tubulin. Bars: 10 |im. 
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Figure 4 
Inhibition of growth factors and its effects on NSC-mediated neuroprotection The 
activity of BDNF, CNTF, and VEGF was blocked specifically with neutralizing antibodies in 
NSC/PNG [bold line] and NSC/PN [thin line] co-cultures exposed to 3-NP [columns B-E] 
Mitochondrial activity [row a], ROS content [row b], and numbers of apoptotic cells [row c] 
in these co-cultures were then compared to those measured in non-inhibited co-cultures 
[column A] and PCs cultivated without NSCs [column F], Blockade of VEGF and CNTF 
activity led to a significant (p<0.01) decrease in the NSC-mediated protection while 
inhibition of BDNF did not have any important effect. When all three factors were inhibited, 
the NSC-mediated protective effect was virtually abolished [column E] and cell behavior 
comparable to that measured in 3-NP-treated non-inhibited PCs cultured alone [column F]. 
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Figure 6 
Proactive effects of NSC grafts on behavioral changes in 3-NP-treated mice Prior to 
grafting, animals were trained in the climbing pole [A] and suspended string [B] tests and 
monitored in a set of five motor behaviors (C; see M & M and Femagut et al., 2002). After 2 
weeks of trainings, four groups of animals were prepared: NSC-grafted (solid lines with 
filled circles), vehicle-grafted (dashed lines with filled triangles), 3T3-grafted (dashed 
lines with open triangles), and intact NSC-grafted (without subsequent 3-NP treatment; 
solid lines with open circles). During and after 3-NP treatment of the mice, motor tests were 
resumed and performed daily until sacrifice of the mice three weeks after the last 3-NP 
injection. The higher the score, the more pronounced were the animal's deficits. While the 
motor activity of the intact animals remained unchanged, vehicle- and 3T3-grafted mice 
deteriorated progressively until days 7-8 when they slowly began to recover. In contrast, the 
motor deficits of NSC-transplanted animals were substantially weaker, which was reflected 
in lower peak values, shorter recovery period, and higher degree of remission. ** p<0.01 in 
comparisons of vehicle-injected and NSC-grafted animals. 
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Figure 7 
Striatal cytoarchitecture in grafted and non-grafted mice three days and three weeks 
post-3-NP intoxication Three days and three weeks after the last toxin injection, the 
animals were sacrificed and brain sections stained with hematoxylin or reacted with 
antibodies against cell type-specific antigens (calbindin, nestin, NeuN, CNP, and GFAP). 
Structural changes in left and right dorsolateral striatum [red circles in the drawings] were 
compared between animal groups. At three days post-3-NP, the striatal tissue of the vehicle-
grafted mice displayed the characteristic, weakly stained spots in both hemispheres [arrows 
in Aa-d], enlarged blood vessels [arrows in Ba], hemorrhage [arrow in Bb, red blood cell 
in insert], pycnotic cells [filled arrow in Be], and necrotic cells [open arrow and insert in 
Be]. In contrast, these defects were not detected in the striata protected by NSCs grafted prior 
to 3-NP exposure of the host [Aef]. Contralateral^, on the other hand, weakly stained spots 
remained detectable [arrows in Agh] At three weeks post-3-NP, even though the striatal 
tissue spontaneously reorganized [Ai-1], a neuronal deficit remained in the non-grafted 
hemisphere (see Fig. 8). While the majority of the grafted NSCs (GFP-positive) remained 
undifferentiated and nestin-positive [arrowhead in Cfg; note a rare mature, GFP-positive but 
nestin-negative cell marked by an arrow in Cg and absent in Cf], the remainder matured 
mostly into GFAP-positive astrocytes [arrowheads in Chi] and only a minority expressed 
NeuN [Bd] or CNP [Be]. No endothelial cells were observed to differentiate from donor 
NSCs. Bars: 300 ^m [A], 50 |im [Ba], 20 pm [Bbc], 10 pm [Bde], 10 gm [Cf-i]. 
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Assessment of striatal blood vessel diameters and numbers of NeuN-positive cells 
Data were collected comparing left and right striata in the four experimental animal groups 
(3 T3-grafted mice represent both mock-grafted groups) and related to numbers of intact 
controls (100%). Evaluations were performed within the dorsolateral striatum [circles in 
drawing] at coronal level 2 as defined by Femagut et al., 2002. In animals sacrificed at three 
days after the last 3-NP injection [black columns], only the NSC-grafted hemispheres were 
protected from serious vascular dilation and decrease of neuronal numbers [AB]. The 
contralateral side and control-grafted hemispheres, on the other hand, always showed 
significant (p<0.01) structural changes and loss of neurons. Similar histology was found also 
in mice sacrificed three weeks post-3-NP (white columns). p<0.01 or p<0.05 when 
compared to intact [** and *, respectively] or vehicle-injected animals [m and u, 
respectively]. 
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Figure 9 
Expression of growth factors in NSC-grafted striatum Three days after the last 3-NP 
injection, the majority of GFP-labeled (donor) cells expressed CNTF [Aa-c, Ba] and VEGF 
[Ag-i, Ba] as visualized by double filters merging green (GFP-positive) and red (CNTF- or 
VEGF-positive) fluorescence signals to become yellow-orange in the merged image [Aci]. 
The mutual interaction between graft and recipient is reflected in simultaneous up-regulation 
of CNTF and VEGF in host cells [red cells in Acijk and Bbc], which was absent in intact 
and vehicle grafted controls [Bbc]. Intensive immunostaining for the factors was detected in 
host astrocytes [SlOO/CNTF-positive but GFP-negative; Ad-f, violet staining results from 
merging red and blue colors] and host endothelial cells [VEGF/CD146-positive, GFP-
negative; Ajk], ***p<0.001, when compared to intact animals. Bars: 50 pm [Aa-c] [Ag-i], 
80 nm [Ad-f], 10 pm [Aj], 5 ^m [Ak]. 
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Figure 10 
Expression of SOD2 in NSC-grafted striatum In comparison to intact [Aa] and vehicle-
grafted-3-NP-treated controls [Ab], three days after grafting, an NSC-mediated up-regulation 
of the anti-oxidant enzyme SOD2 was observed in both host [red in Ac] and double-stained 
donor cells [yellow in Ac]. About 60% of NeuN-positive host cells within the grafted area 
also expressed SOD2 [red in C]. While striata in intact animals remain negative for HNE 
(marker for lipid oxidation during oxidative stress; Ba), 3-NP exposure of vehicle-grafted 
animals led to elevation of oxidative stress and HNE levels [Bb]. In contrast, in animals 
receiving NSC grafts prior to the intoxication, the up-regulation of SOD2 appeared to be 
associated with lower but still noticeable levels of HNE [Be]. Bars: 80 |im [Aa-c], 40 |im 
[Ba-c], 10 pm [C], 
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Scale used for the scoring of motor symptoms 
General locomotor activity: 
0 - normal locomotion, rearing, and grooming 
1 - decreased locomotion, rearing, and grooming 
2 - no locomotion; mouse is sedentary and exhibits 
almost no rearing or grooming behaviour 
Hindlimb dystonia: 
0 - no hind limb dystonia 
1 - transient or permanent increase in hindlimb 
spread, crouched posture with no changes in gait 
2 - wide spread of hindlimbs, poor hindlimb 
movements and coordination, pronounced crouching 
posture and impaired gait 
Truncal dystonia: 
0 - no truncal dystonia 
1 - visible kyphosis and flexed posture 
2 - severe kyphosis and flexed posture 
Hind limb clasping (tested by suspending the mouse 
in mid-air) 
0 - hindlimbs are fully extended, spread out, and moving 
about; mouse attempts to straighten up 
1 - intermittent clasping of hindlimbs; hindlimbs are not 
fully spread out and the mouse shows weak attempts to 
straighten up 
2 - hindlimbs are fully drawn up to the abdomen and there 
is virtually no attempt by the mouse to straighten up 
Postural challenge: 
0 - Normally, the mouse cannot be tipped on its side 
1 - the mouse can be made to fall on its side but also can 
slowly get back on its feet 
2 - the mouse can be tipped on its side and cannot get back 
on its feet by itself 
Table 1 
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CHAPTER IV. GENERAL CONCLUSIONS 
We have investigated and characterized NSC interactions with its microenvironment 
leading to neuroprotection from oxidative stress, in vitro and in vivo. The two investigations 
in this dissertation (chapters II and III) present novel data describing the mechanisms 
underlying the neuroprotective potential of NSCs and provide important information for the 
field of stem cell biology. 
The major findings of our research have already been deliberated upon in the 
discussion sections at the end of each chapter. The overall conclusions derived from our 
studies, and some suggestions for future research will be presented here. 
NSCs and resistance to oxidative stress 
In this dissertation, we presented the first report (Chapter II), which analyzed 
sensitivity and reaction of NSCs to oxidative stress in comparison with post-mitotic neural 
cells, and the extended implications in terms of CNS regeneration and repair. 
Recent reports from the group of Noble M indicate that in stem/precursor cell 
populations, intracellular redox state is an intrinsic property which regulates self-
renewal/differentiation and responsiveness to environmental factors (Noble et al., 2003). 
Additionally, a couple of other groups have shown, by expression profiling of stem cells, that 
there is a subset of genes, enriched in hematopoietic, neural, and embryonic stem cell lines, 
which provide resistance to stress, including oxidative stress (Ivanova et al., 2002; Ramalho-
Santos et al., 2002). These enriched genes control the core stem cell properties ("sternness") 
that underlie self-renewal and differentiation. 
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The outcome of our studies, considered in conjunction with these works, permits 
some general conclusions to be drawn: 
The first is that NSCs, by default, appear to be better equipped to control intracellular 
ROS than post-mitotic neural cells, and hence may be inherently more capable of surviving 
in oxidatively stressed environments. This conclusion was substantiated in vitro by the 
measurement of significantly higher mitochondrial activity, lower ROS content, reduced 
tendency to undergo apoptosis, and presence of comparatively higher basal levels of 
important free radical detoxifiers such as UCP2 and GPx in NSCs. In vivo, we discovered 
that endogenous NSCs localized in the SVZ niche are also characterized by higher steady-
state levels of UCP2 and GPx when compared to neighbouring neural cells in the brain 
parenchyma. This observation is in accord with our in vitro results, and shows another 
attractive property of neural stem cells, namely their natural ability to combat oxidative 
stress. 
The second conclusion is that NSCs react more quickly and in a stronger fashion to 
oxidative stress, than post-mitotic neural cells, by up-regulating their proliferative activity 
and importantly, also critical anti-oxidant molecules. This was exemplified in our study by 
the greater NSC ability to up-regulate GPx, UCP2 and SOD2, in response to 3-NP. In further 
support of the key role played by these anti-oxidant molecules in the observed process, their 
inhibition reduced NSC resistance to 3-NP significantly and made the NSCs behave more 
"like" the post-mitotic neural cells. One may therefore speculate that an essential feature of 
NSCs which helps them survive in a hostile environment is their high expression of ROS 
metabolizing enymes and ability to up-regulate them. 
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Finally, and interestingly, even though there were some variations in the 
"preparedness" and response of the immortalized and primary cells to oxidative stress, the 
cell behavior differences between NSCs and post-mitotic neural cells within these groups 
held true in the case of both these cell types, and also other NSC lines utilized (unpublished 
observations). Therefore, the third conclusion that arises from our studies is that "resistance 
to oxidative stress" is a very basic and fundamental characteristic of all neural stem cells. 
In summary, the high expression of protective molecules and the resulting greater 
resistance of NSCs toward oxidative stress, compared with related neural cell types, may be 
part of their "sternness" feature. This attribute may help NSCs survive and be therapeutic 
under conditions of free radical-mediated injury. Further analyses of such stem cell features 
will significantly impact current concepts in CNS development, regeneration and repair. 
Soluble factors and NSC-mediated neuroprotection 
In the study presented in chapter III, we analyzed graft-induced host plasticity, 
specifically with regard to NSC-mediated neuroprotection from oxidative stress, and 
determined some of the contributing cellular and molecular mechanisms. 
In vitro, we observed that the presence of NSCs before the 3-NP-induced oxidative 
stress resulted in a significant decrease in free radical production, and improved cell survival. 
This data indicates that NSC-mediated neuroprotection is plausible. Further, in vivo we 
observed that the NSC transplanted animals showed only a mild motor disorder on 3-NP 
intoxication when compared to the non-transplanted controls. Also, on histopathological 
examination, grafted mice showed increased neuronal cell counts, decreased oxidative stress, 
and striatal damage in the transplanted hemisphere. The NSCs when analyzed revealed that 
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they had remained mostly undifferentiated (Ourednik et al., 2001; Ourednik et al., 2002) and 
the surviving neurons were primarily of host origin. Also, in conjunction with our previous 
study presented in chapter II, the NSCs themselves had resisted well, in vitro and in vivo, the 
3-NP induced oxidative stress and survived. Thus, this study for the first time demonstrates, 
both in vitro and in vivo, that preventive transplantation of NSCs, which are on their own 
quite resistant to ROS toxicity, may protect host elements from future oxidative stress insults. 
Recent evidence suggests that undifferentiated donor NSCs can spontaneously 
express trophic factors (Lu et al., 2003; Toda et al., 2003; Imitola et al., 2004) and also 
exhibit neuroprotective potential due to their capacity to express these factors under stress 
(Ourednik et al., 2002; Park et al., 2002; Teng et al., 2002; Ryu et al., 2004). Our studies 
lend further support to these findings. In vitro, we found that a large percentage of NSCs 
secreted CNTF, VEGF and BDNF after co-culturing and treatment with 3-NP thereby 
providing a molecular basis for the observed neuroprotection. Similarly in vivo, we 
determined that a significant proportion of the NSC population expressed VEGF 
(demonstrated in vivo for the first time) and CNTF in NSC-transplanted animals which 
showed minimal 3-NP induced motor and pathological changes as compared to the vehicle-
injected controls. Functional inhibition of these factors in culture resulted in a significant 
reduction of the NSC-mediated neuroprotection, supporting the crucial role of these factors 
in the observed phenomenon. Thus, a local elevation in the levels of these factors in areas 
prone to degeneration probably contributed to the NSC-mediated cell survival in vitro and in 
vivo by stimulating pathways counteractive to oxidative stress and cell death (Koh, 2002; 
Abid et al., 2004; Eyries et al., 2004; Kaur et al., 2005). These findings in particular point 
out that utilizing NSCs to achieve targeted delivery of such neuroprotective agents to areas at 
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risk to degeneration can help prevent neuronal dysfunction and atrophy. Also, these findings 
highlight the possibility that factors such as VEGF, traditionally not connected to the nervous 
system, may play an important role in NSC-mediated neuroprotection. 
Interestingly, up-regulation of the aforementioned soluble factors after 3-NP 
intoxication occurred only when the NSCs were already present. In other words, NSC 
transplantation directly induced high expression of these growth factors. Introducing the 
NSCs may have helped modulate the rigidity of the mature CNS and led to neuroprotection 
by creating an environment more similar to that during embryonic development where 
regenerative and plastic occurrences are more common. Thus, one may hypothesize that the 
CNS might possess a set of inborn programs (such as those related to neurotrophic factor 
expression and neurogenesis) which not only ensure normal development but also help 
maintain homeostasis in pathological situations. NSC transplantation may help the re-
emergence of such dormant mechanisms from within the host CNS. In consequence, future 
exploitation of stem cell biology, including enhanced release of therapeutic factors through 
genetic stem cell engineering or otherwise, might constitute promising approaches to treating 
diseases of the nervous system. 
NSC-host interactions leading to neuroprotection 
It is now known that stem cell interactions with localized space and time cues 
regulate their behavior, fate and plasticity in the nervous system. This socializing between 
NSCs and their neighbouring cells leads to dynamic cellular and molecular changes in both 
these entities. Although there exists a hypothesis (Doetsch, 2003; Alvarez-Buylla and Lim, 
2004; Wurmser et al., 2004) with regard to events in NSC signaling with its 
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microenvironment, and the cell-types involved, none have addressed this issue in detail or 
shown any specifics of the interactions. The study presented in chapter III is the first to 
address and characterize some of the graft-host interactions in the context of NSC-mediated 
neuroprotection. 
We found multiple evidences for the involvement of the cellular microenvironment, 
in the observed NSC-mediated protection. Firstly in vitro, our co-culture studies pointed out 
that the NSC-primary astrocyte communication increases the efficiency and success of the 
protection of primary neurons from oxidative stress-induced cell death. Specifically, the 
coordinated effort of both NSCs and primary astrocytes resulted in a significant increase in 
the production of the soluble neuroprotective factors VEGF, CNTF and BDNF (when 
compared to the condition when primary astrocytes were absent in the co-culture), and led to 
the activation of appropriate defenses against oxidative stress-induced cell death. These, 
astrocytes are known to be important regulators of the stem cell niche and have shown to 
promote the proliferative and neurogenic abilities of NSCs (Song et al., 2002; Doetsch, 
2003), They are also known to be vast repositories of many different trophic and 
neuroprotective factors (Ridet et al., 1997; Petrova et al., 2004). Our results are in accord 
with these reports and we further explain their connection with respect to NSC-mediated 
neuroprotection. 
Secondly, supporting our in vitro observations, NSC interactions with its 
microenvironment also played a crucial role in neuroprotection in vivo. Once more we found 
evidence suggesting an important role for the regional astrocytes and additionally, 
endothelial cells in the observed NSC-mediated neuroprotective process. Many host 
astrocytes were observed to be immunoreactive for the neuroprotective factor CNTF, in 
135 
NSC-transplanted animals in our studies. Also, a large proportion of the NSCs themselves 
were also found to be expressing CNTF. This elevation of CNTF expression in the NSCs 
and host astrocytes may have promoted the maintenance of both these cell populations (Ip 
and Yancopoulos, 1996; Emsley and Hagg, 2003). In turn, and more importantly, the 
increased levels of CNTF may have had direct and indirect (via astrocytes) neuroprotective 
effects on the host striatum and prevented it from degenerating. With regard to endothelial 
cell-NSC signaling, many NSCs as well as host endothelial cells in the transplanted animals 
were found to express vasculoprotective and neuroprotective factor VEGF (Storkebaum et 
al., 2004). Since these findings could not be made in the mock-transplanted controls, they 
were a direct response to the presence of NSCs and pointed to a cross-talk between NSCs and 
endothelial cells. Such NSC-endothelial cell interaction may have stimulated both these cell 
types to reciprocally secrete VEGF, which in turn, and in addition to its vasculoprotective 
effects, could have had a neuroprotective effect on the surrounding host neurons, and also 
neurotrophic and neurogenic effects on the NSCs themselves (Shen et al., 2004). In 
summary, NSC communication with host astrocytes and endothelial cells led to an 
amplification of VEGF and CNTF and later neuroprotection. These data indicate that NSCs 
can "interrogate" the host microenvironment and elicit plastic responses from within it in a 
pathological situation. Also, growth factors can be a critical medium through which NSCs 
and the host cells "talk" to each other. 
Another question addressed in this study is how increased growth factor expression 
leads to neuroprotection. We observed up-regulation of the antioxidant enzyme, manganese 
superoxide dismutase (MnSOD/SOD2) and reduction of oxidative stress markers in the host 
neurons in the NSC-transplanted animals in vivo. Similarly, in vitro, the presence of NSCs 
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stimulated an increase in the expression levels of SOD2 after the 3-NP insult. As mentioned 
before, VEGF expression was observed during the neuroprotective process. A cause of the 
SOD2 up-regulation could have been VEGF as it has been previously shown to have this 
capacity (Abid et al., 2001; Abid et al., 2004). In further support of the causal role of VEGF 
in OD2 up-regulation, we observed that VEGF blockade in vitro led to the inhibition of 
SOD2 and NSC neuroprotection. Therefore a combined graft-host effort, resulting in VEGF 
mediated up-regulation of SOD2 in concert with neuroprotective effects of CNTF, may have 
contributed towards the prevention of oxidative stress and host neuronal degeneration. These 
results point toward the direct involvement of growth factors in the observed antioxidant up-
regulation and provide an example of how they can be neuroprotective against oxidative 
stress. The schematic in figure 1 summarizes a possible sequence of graft-host signaling 
events which lead to neuroprotection in our model of 3-NP induced oxidative stress and 
neurodegeneration. Of course, the specifics of such NSC-host signaling may change 
depending on the particulars of the pathological insult, age of host, nature of NSCs among 
other details. 
In conclusion, this dissertation, for the first time, elaborates on the pivotal role of 
graft-host interactions in NSC-mediated therapy and sheds light on some of the molecular 
events which may be involved in these interactions which culminate in neuroprotection 
against oxidative stress. Specifically, this thesis illustrates how NSCs can network with 
neural and non-neural cells of the host CNS, such as astrocytes and endothelial cells, to 
prevent an impending neurodegenerative event. 
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Neural stem cells 
(equipped with robust antioxidant capacity) 
I 
Transplantation 
I 
Initiation of cellular interactions in the NSC niche 
3-NP intoxication 
(oxidative stress) I 
Astrocytes 4 > NSCs < > Endothelial cells 
\ I / 
CNTF and VEGF production 
SOD2 up-regulation 
and stimulation of 
other anti-oxidative stress 
pathways 
I 
Reduction of oxidative stress 
I 
Neuroprotection 
Figure 1: Possible sequence of events underlying NSC-mediated neuroprotection from 
oxidative stress 
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Future directions 
A number of further experiments can be suggested based upon questions raised by 
our results. In terms of the observed NSC behavior under oxidative stress, it would be 
important to understand the signaling pathways which are activated to allow the NSCs to be 
more resistant to oxidative stress. Also, the susceptibility of endogenous NSCs to oxidative 
stress should be further examined and ascertained in vivo. This thesis already examines this 
question in vitro. 
Since NSCs showed the promise of neuroprotection in our in vitro and in vivo models 
in a certain time scale, they should be transplanted at other time points before and after the 
pathological insult, in other models of neurodegeneration and in various age-groups, in order 
to further explore the interplay between NSCs and their extracellular milieu. Also, NSC 
transplantation should be carried out and the resulting graft-hosts interactions analyzed in 
more complex species such as primates to test further their potential. In terms of the role of 
soluble factors such as VEGF and CNTF, which were found to play a crucial role in the 
observed neuroprotection in our studies, one could understand better their role in 
neuroprotection by utilizing NSCs which over-express these factors or through in vivo gene 
transfer techniques. Signaling pathways by which these factors can prove to be 
neuroprotective are still not clear, and would also need to be elucidated. On another note, the 
role of injury induced cytokines and microglial cells, ECM and cell adhesion molecules, 
which may also play an important role in the dialogue between the NSCs and the host 
environment, should be studied. Insight into their contribution and role in the repertoire of 
events which unfold after NSC-transplantation will significantly impact present views on 
NSC therapy. 
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